Index,Bcell_general,Memory_Bcell,Naive_Bcell,Plasma_cell,CD4_Tcell,CD8_Tcell,Memory_Tcell,Naive_Tcell,Tcell_general,Cytotoxic_Tcell,Exhausted_Tcell,Immune_checkpoint,Treg,NKcell,Innate_lymphoid_cell,cDC,pDC,Macrophage,Monocyte,Myeloid,Granulocyte,Mast,Erythrocyte,Platelet,Stem,Stroma,Pericyte,Fibroblast,Endothelial,Epithelial,Mesothelial,Adipocyte,Hepatocyte,Pancreatic,Pneumocyte,Apoptosis_pathway,IFNg_pathway,TGFb_pathway,Cytokine,Cell_proliferation,TLS,Genome_integrity,Reference,time,event,cohort,ICI_target,ICI,cancer_type,response_label,TMB,risk_score,Pred_Risk,best_alpha
NSCLC_Ravi_SU2CLC-CLE-NIVO10-T1,0.10561283678283025,-1.580891746523629,-0.02254162438794241,-1.0701841217857333,0.6469803977600485,-0.4169705640476931,-0.19656907648109667,-2.189090088142905,-0.23668766930205482,-0.015944534442822934,0.18481853861988173,-0.9444527486855576,-0.9127189690572646,-0.5419425514604266,-0.0406006011135041,-0.2765466430999776,-0.2461110972173964,1.1902351755381357,1.168621045838365,1.5514502077596626,0.8194900739949424,-0.45271592351477014,0.12858678919787217,1.3581586104239487,-0.11602319584972938,1.5147243050091919,-0.4362634750371907,1.8583797556218675,2.3353522083786844,0.6191914174946833,-0.22263116487908638,-0.602195844723933,1.0254423727562436,-0.161209973874676,1.8683446901678413,-0.29096531995922376,-0.10681650358850267,0.3455749656632572,1.035370124299651,-1.0621171249521661,-0.22226826824881954,-1.5596537421911623,-0.5297902919122183,2.8666666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.9599348137256912,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO18-T1,0.7256878805393048,-0.7377558517815197,0.028963842974431504,0.9048012707957065,0.06773230795176217,0.5822757737834077,-0.423133928621789,-0.0011892477527967106,1.0388273261645686,0.6045381660852104,0.8613339020118309,0.7084314559594704,1.5149428850990045,0.035700321361852035,1.4899306503763199,0.11439629374909549,-0.29198872618333555,1.079268727974408,0.563810051759599,1.247918777432063,0.20106523707497845,0.09326539764687024,-0.21985909017293967,-1.649539688861734,0.2912869596034258,0.7228896755920848,-1.3545981883954685,0.4797049388205175,-0.031289796181280916,0.6808597577263871,-0.35297020086521824,-1.3273085087166612,0.2610298906303745,1.4677746956613602,3.4650458810578617,-0.09708515173639208,0.9488747963156049,-0.048675353083774124,1.4298900427865504,0.27327534935561976,0.7649700237094404,-0.04389604678929389,0.9950216462629057,5.366666666666666,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,149.0,0.6108897293128317,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO19-T1,0.8012691594702372,-0.2980920418341196,-0.10328462713042019,0.47941866335545374,-0.013417813456227383,0.5505780770171887,-0.21605458980226655,-1.4082327023453212,0.41464999721561047,0.6818739719648068,0.8542100295086482,0.8778050677451278,1.1563029437432284,-0.012141691474601706,0.9007393780964695,0.8746845236501349,0.4171490710338331,0.43290142979690477,0.24811340996937628,0.5312166025237309,-0.0824852387758178,-0.20111367397558438,0.2406325680104212,-0.9467888338486135,0.4976267820511168,0.7554066956133496,-1.149916764375893,0.3237325699920229,1.8178963596237243,0.7192037238221157,-1.4862115422155322,-0.8728814732659335,-0.18663410708962638,-0.3136731305655552,3.1291165558467133,0.12181583110326125,1.035200917669534,0.8959428880775611,1.6427695909407063,0.3657848117697595,0.7266069794582665,0.275774540863389,0.7625512563935024,9.9,True,SU2CLC1,PD1,Nivolumab,LUAD,R,602.0,0.6272533147619426,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO20-T1,1.3008095830930282,1.3538306359121544,1.3566101630904084,0.5763340607859017,1.1575160822588224,2.5243441720895015,0.40765313610177345,-0.1182167079923928,2.494059604506681,2.942753357486064,2.032992364027106,3.2137220988122057,1.5661808214832813,1.4140647784249996,2.9979546146720364,0.18762838409813806,0.1384653649590544,1.161934731509182,0.5349458662086534,1.0195736212676751,-0.877757259934265,-1.3314893005275934,0.7093928744876746,4.160583166103312,-1.582362790729145,-2.324070348994018,-3.5952723083551903,-1.5211861481263873,-2.130667029825328,0.13303020104994548,-2.37159007809376,-0.2666926003668519,-0.13233508898381813,-0.9384825450632978,2.35444087419558,0.7469755827313295,2.4752574280838724,-0.96770064179471,1.5110155507975245,0.5905175154606693,0.8966224590999077,1.2251512062627279,1.0331327959346255,9.1,True,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.4676110421753882,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO2-T1,-0.13382410844921444,-0.3244285956480436,-0.46572620680786386,0.34991944798893265,-0.21082075556921134,0.4922687974538367,-0.6295643918879699,0.611895096923125,0.8100500012990837,0.7811203589192494,1.057166579371506,-0.19617443179133515,-0.5468048227141232,-0.697911038582906,-0.5042630514378318,-0.3304769217079936,-1.3085047645258312,0.37523311303984375,-0.2433211687656455,0.29665721082850954,-0.9784888270733851,-1.928164055269284,-0.12438218681685984,2.950661164273009,-0.02840032388478739,-0.8221171773514251,-0.21176582189439538,-0.5390163182075014,0.6588468007649347,-0.9617357912627013,-1.397049885218377,-1.1339180300326426,-0.04991079795488766,0.3015035584805599,2.142042215161117,-1.3961763387601105,1.2450717687071007,-1.19370385246125,-1.124267423292299,-0.20148406188298532,-0.17646660927374,-0.2682832327672791,0.9912350644756525,4.1,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.5482741817099226,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO3-T1,-0.4673669853881742,-1.4756585871865382,-0.6652593285831968,-0.3979474578240824,-1.8049285184276822,-0.9266012192067233,-2.5823766656625664,-1.329621658202878,-1.242864085494784,-0.08553814205591731,-1.7832627355676125,-0.8908073463725507,-0.9878178933327039,-0.08631099484077544,-0.6837886646801071,-1.4693532978705144,0.15445761863724375,-2.0815174452692413,-2.043250789001439,-2.0679343799620313,-1.5040788367402993,-1.2759706213037694,-1.3116689526104157,-1.3123918599916575,-0.5158447963469568,-1.3230527249051043,-2.5140393478636764,-1.5899772107773837,-1.7749533531704962,0.23252286736463226,-0.9021359342854469,0.45132664623557683,-0.09037377374506136,1.9155200540845991,3.7074753123901103,-1.1947977350925216,-0.6870726394577025,-1.6597659890704175,-1.6369765903167721,2.185119778076508,-1.1187638863814264,2.819628874381313,1.3109186005502436,21.2,True,SU2CLC1,PD1,Nivolumab,LUAD,R,84.0,0.6272040401834705,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO52-T1,0.2598096551698902,-0.8783755866906727,-0.8639122838907263,-0.8527620408811829,0.6072890263323244,0.09777364046886944,-0.15806500528883768,0.16643773663956773,0.9554820952645141,0.6857165226575009,0.3049227023275269,-1.8432718803456953,-0.17188643150047803,0.5170835666081474,0.8341931967547742,-0.12365250786469505,2.165896548019482,0.6403101686300977,0.6125729947074761,1.111058860491241,0.5963095600904753,1.4420709215835896,0.19478485909067006,1.140025518256994,1.2160800768889368,0.5484373217340954,-0.8470422066686196,0.3248303236884294,3.9182708918216727,0.5103966351433389,1.0840751021893518,2.411194131535804,-0.31710557479483376,1.0806326701314717,5.342506955501391,-0.5263132597684568,-0.7710040344875863,0.2863364316684502,0.33655318646115084,-2.018368193551258,0.5002450994436457,-3.0318346095356383,-1.33363108877993,30.366666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.4913605741703848,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO5-T1,1.7189160697001589,-0.010193242450387946,0.8740437798912405,0.4069411785917527,0.5185784451377552,0.7363493266793417,-0.06198266990230966,-0.41126700942711075,1.1171320716167898,1.403423800004407,0.6422373792659369,0.1517691758264125,0.8809077630418964,0.08324564244219397,0.768189433191048,0.14549632678318064,0.47212793553978766,1.0515844380413977,-0.6257240431027343,0.3002949588356828,-0.645508749380727,-1.1512651279672208,-0.1513244572946524,0.755163654030094,-0.2984554170158886,-0.11151705367261999,-1.8241577935845446,0.1638322546091517,0.4345322983068552,1.055098301534626,-0.0486198776049132,0.9005747342667177,-0.2197937091482395,0.07586742645726034,0.8991918943514171,-0.0999431838988885,1.357852253975171,0.5792261675958972,0.21899394414199547,-0.05090460909585845,1.0875336980890187,-0.6672985568651352,0.7784310217164556,18.23333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,R,623.0,0.6920053225496766,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-CLE-NIVO9-T1,-0.6765274479322039,-1.0704711435330674,-0.5496276302225795,-0.545567476983818,-0.748762495756793,-0.4119784640289062,-1.1834481087226059,-1.437628183830385,-0.24188806452600198,-0.21846504473617567,0.2502172740697535,-0.8206290819830235,-0.3809390820863484,-0.6469429830737445,-0.38122091917834156,-0.28689367893355217,-0.7991846755646671,0.6074595937539561,0.191756457395029,0.8974218471068839,1.883333108159482,1.6463496879768367,0.22670122019840963,-0.20729571065461205,1.1226480537117818,1.7019935251416531,-0.5825590001233626,1.8454652380803833,0.8818174476569346,1.3192801526114666,1.4463049264555186,-0.7137876014150816,0.3660982888610416,0.37783957269339735,1.3801287904380826,-0.7398008638316007,-0.4276701090917416,1.3445119007970698,0.5062867108302683,-2.0973044004863106,-0.10700623021239468,-1.621911292380694,0.24576502292928423,13.466666666666669,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,296.0,0.7992766863780493,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1008-T1,3.6277452772103387,2.0843976981161703,4.044024469211342,1.6252394865539184,1.9118878650056672,1.5110995354042691,0.08591631303329803,1.8005988998368974,1.6715370397757725,2.0618195824335044,0.5992088890552862,-0.01810655553458615,2.0913942849370026,1.715598630806689,1.9358805081526027,0.5069147418605071,1.6018693776713662,-0.6951328497117006,0.609177597655588,0.512930997402914,0.44182934916472955,-0.3040445084086402,3.340158163003155,1.6616621001117726,-0.4273711042757584,-2.4795643840219883,-2.032590911633797,-1.8091825169292426,-1.483421388191782,0.8689692294862706,-2.042240326442288,0.3497145733735635,-0.05607382482914968,-0.178878100311522,4.568317522304057,0.46309660724350743,1.3236075177377074,-0.9618090913174727,0.5198610278943769,0.6328831411701301,1.4689746624533129,0.5896445969590293,0.6985044996755889,7.9,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.736801992257146,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1017-T1,1.445880315073751,0.8356496155320593,0.9693963520134065,0.7013429540830493,-0.058695177208357534,0.032310713955904076,-0.16830650507109182,-0.39392876023305456,0.23178153914565863,0.7140022275942969,-0.5935719318729652,0.28371033092230863,0.8810793631171642,0.7374195951752284,0.143286501356379,-0.22961957897138324,-0.6993577058646299,0.6493361087014418,-0.3490846530470497,0.2863209140995407,0.5226194849852169,-0.04093132660399705,0.7554881504652086,-0.8672356707558139,-1.4402205406560376,-3.4588167072882268,-2.762659534677517,-3.3227717135030965,-2.11022450942223,1.124400457490186,-1.8434312814504499,-0.07975358394891183,1.5326715038597478,-0.013956032157272435,3.6947659031479185,-0.11811706194268853,0.307238480450039,-1.1957184274140222,-0.024830519878418545,1.5102869759860347,0.23986081985697677,1.4313373730569057,1.240611375598701,7.5,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.6805757710697563,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1020-T1,0.4996428087319835,1.2925814984792514,-0.4523254535268584,1.2588441454885955,0.8864178350217001,0.8177239017822386,0.9007841931578747,0.014268356798861213,1.4022319419883849,1.2126800019862534,0.3227495750942558,0.25825392703377525,-0.6404780301466771,0.029861784493603282,1.3237805865170715,0.8350935456069487,-0.0019104608126399628,1.5220456807740026,1.4072463904896706,1.0557975670071584,0.5082878033313253,-0.25851716819195536,0.14634706615024,0.313827220870186,0.37872051889830505,1.0435129648765977,1.0640493945801428,0.8883445270950386,0.959716234805808,1.6211731397129834,-0.3303754536570268,1.6236275348674443,-0.0463153625234261,0.3486218317983538,3.270308357498312,-0.6950515123525268,1.2856013509369917,0.8301870280666724,0.858214728043447,-1.0654493927957174,0.8867119237371323,-1.9114886513235467,-0.04115356332122414,12.133333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.6775252792491123,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1021-T1,-0.8195863106750373,-0.08668767636466308,-0.40597724061410073,-0.25861693608164554,-0.07633148541311911,0.7261985720953121,-0.628021185205163,-0.9963558448665826,0.5823060614506469,1.0037595379469393,0.3479879318847881,0.720539167314575,0.9719170349335612,0.29477477609174335,1.0691483050981099,0.6512380514773781,-0.462365090288837,1.7098919409349809,1.2575469315116208,2.039532109956164,0.9510915831878199,-0.4794106361840371,0.8014745242521594,0.09847944443204273,1.7462528174725205,1.6465979182755484,-1.285502067256645,2.053613707038911,1.9119641812596981,0.45316838388789643,1.295264180044233,1.3346610719358858,2.6831262140878054,0.046398868427347015,0.11192463853753232,-0.3714535448340208,1.0422964815968665,1.2224689935903181,1.2161148751470043,-1.3607805530529173,-0.061826616751853074,-1.210501818882735,0.1141071915081206,6.033333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.7971847094383495,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1022-T1,-0.7160002140760546,-1.4645837435487523,-0.7338284060882584,-0.15333575167434144,-0.46672049998187154,-0.4548050728655085,-0.34541678837507084,-1.6738509603538716,-0.2792164912896599,-0.17591902379405025,0.5728158424440445,-1.1504445460805162,0.09851389507316848,-0.7557855838621014,-0.750691299195927,-0.28466765966040325,0.1698351756506846,1.072785138530622,-0.3258172201954994,0.6280132774659233,0.25271690591182117,1.0529964910232226,0.6794437552360757,0.6384358285263692,0.5726872756461113,1.7382356082424764,2.723847718107406,2.286315796596219,3.3271804000589915,0.6570440679900884,-0.12878749691062846,-0.14500977659343517,-0.06191761338324678,0.7199499843947671,2.9851535339460407,-1.0476745662148246,-0.6574906438014491,1.4528493250847492,0.722851109854994,-2.4754272550856053,-0.5837950408081888,-1.9268326018462028,-0.03993879329408295,2.6,True,SU2CLC1,PD1 + other,Pembrolizumab + Carboplatin + Pemetrexed,LUAD,NR,,0.7696344399729483,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1023-T1,2.4707727377750643,1.3808738053486977,1.509221474597478,1.566534033104836,1.0408773253541985,2.0248746949635272,-0.006269782916331851,-0.36440230526347345,2.0721958692790396,2.240256688393134,1.0541673556519613,0.9207987300314674,1.8669265514389475,1.2746238087902686,1.3405294425109806,1.1275124596566233,1.4705011726058836,1.1450502009966934,-0.5524024699241056,1.563509332840593,0.14609923264402616,-0.4417706338255507,-0.660377832914558,-0.3494630847545157,0.532707216392444,1.4244389181217187,1.121409630789464,1.4661567526068209,2.910575394971368,0.4500485846537785,0.3115228334434214,0.6430720187730539,-0.3183354744687898,-0.40532758900402566,4.307629835327312,-0.18684889639629587,1.8215448089835937,1.268460059107107,1.2949640246082963,-0.716991689238982,2.3258911581258466,-0.44831524356240054,0.8345961662404906,6.566666666666666,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.28731241592896356,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1026-T1,-0.7362604895894089,-0.6916089663694548,-1.0060479740622663,0.14328533480567782,-0.4361785071051515,-0.07565307335049937,-0.5187528989653221,-1.2754194053089007,-0.1696409479061957,0.015002575117615808,0.6716021801531906,-0.17150156304015068,1.441489700563993,-0.4784841972894563,0.5154334189732933,0.12261305762251312,-0.5435573996128664,1.7481680362402356,1.5932835335895723,1.8485984000565296,2.02764600238985,1.4480728145647195,0.33747672008344215,2.6499797212100735,0.3812786582809625,0.4569596274517414,-0.29566590203769205,0.9005478265188891,1.0674272005932026,0.7994786300641201,-0.7967300400369943,-0.5786380553459383,0.6124872785472015,1.286710731762625,4.670848109498345,-0.5566947041954416,-0.0902747045507409,0.5624570537408387,1.054987571640642,-1.3589681462929415,-0.24980890648003357,-1.3640035550921095,0.7554294862640073,9.5,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.8603662006090173,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1029-T1,0.33778512823521584,1.556039442677715,-0.11604694252199013,0.7787687894882082,0.2647724385743979,1.2602433078345596,-0.404232235222555,-0.7927214893160615,1.292328810708929,1.8338101154480304,1.380877061360043,1.9463771699502386,1.403819499952071,1.060309776279556,1.0744124426054709,1.013122111412063,-0.1384642856949664,1.8481171148351214,0.1568383786280614,1.3615092598038148,0.7538048247651019,-0.04022091894433629,0.6122940847427497,0.6636365935351258,0.5713851455972961,0.6494553125865761,-0.34959440514447293,0.2994902467023985,0.8363868351145131,0.4598193734378979,-0.07783848116332828,0.7437379116862005,-0.31073366592574875,1.216570195163723,3.6548750048651373,0.18763138481163333,1.7228160466809952,0.30979540104383413,1.7841472842062465,1.255880251670132,0.9455359700675834,1.3259575205186342,1.092762087923759,17.0,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,398.0,0.43903574717349203,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1031-T1,2.6696043295549083,1.8842005893884568,2.202610914980306,1.592719435316183,2.1564165135320743,1.1142418649190362,0.9187083550348246,1.7358513961756339,1.4988367594489984,1.010194393865779,1.4871576337104009,1.620824281762117,2.901331562718089,1.4644959959068977,1.946325788507511,2.1438877252356465,0.8247766590163367,2.1158188901959973,1.4677492443508466,2.0685422743695043,1.1776586179066646,1.0198083062355525,1.0542826439431325,1.4495602245294692,1.0952260148142698,0.7192838567878463,-1.199737768881218,-0.022533495358067344,1.0640794904779862,0.49823767057011514,-0.2578003203346142,0.8087917892242522,0.6692150723789283,-0.006026961397568759,3.310391414299107,-0.011174302881859971,1.5148771052204437,0.4640872405535887,2.426354326648987,-0.056414992695513415,1.7950353355164574,-1.078613663029841,0.605888709027683,6.333333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,240.0,0.49386051870357284,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1032-T1,-0.2594752887348581,1.6867225663639318,-0.8056101727185816,0.12994399560099773,-0.9734598562734122,-0.6004631450886062,-1.4134734331359866,-0.9893628607587176,-0.9239104626259637,-0.18053207834036641,-0.8476068655879854,-0.28192765989750473,-0.2863643042292631,-0.767046522748243,-0.9261690688007408,-1.209473946167227,-0.35917764554111625,-0.29361223610595255,-0.8437767549227613,-0.15147126386224427,-0.5001291352858924,-0.13989277285389304,0.455404619737851,0.23025579130213036,1.2821035000265322,1.0005704574677252,-1.3191885047030802,0.8020273053637664,0.32248571237798634,0.8009871780649235,-0.8657613921723154,-1.3315820663833153,0.10564731553702852,-0.49707483865135144,3.857644482493247,-0.7816703377554334,-0.7970494813319937,0.6023700687140654,-0.4528269725070849,-0.012470784198131067,-1.0672096370406934,0.4041258193479969,0.6261462285339637,12.933333333333334,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.8420124536219642,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1033-T1,0.41733168847855967,-0.23070291126420092,-0.7719292554610732,0.3450964825483173,-0.16741532663083467,0.17764118968702694,0.3396154340113013,-1.1976951287247855,0.42149219064059745,0.5725109741203669,-0.1763899747890825,-0.4920807782167974,0.9180729682986174,-0.7367201332375666,0.5975858997969581,0.835945483607152,0.14677623649387664,0.9198255372656635,0.358485907376617,1.1104042427070924,1.3969428261693846,2.108771857880458,-0.2103320718591432,-1.2248051756830558,1.682891616705631,0.8646884680124363,0.2318332038951623,0.9054012604003945,2.0665226470539517,0.5402664761502529,0.6252125480665381,0.6454047032872051,0.5709486297125728,1.0976381087680294,5.313814863306662,-0.7753231437678064,0.31181521393712075,0.3517741509479169,0.6299635028901255,-2.0826973667501063,0.9218336349798075,-2.0540929932732106,0.86676463476433,11.233333333333333,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,NR,175.0,0.5076698112157009,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1034-T1,-0.7855284834320451,-0.35324756077820685,-0.8472364813244606,-0.261180600913863,-1.0027902946011014,-0.4910179194478843,-2.2090650276704666,-2.299207120340835,-0.6255683562739366,-0.27399880796634585,-0.5735450014876118,-0.25883164588260216,0.44150178777331317,-0.4984668570915477,-0.08627759141689051,-0.1425765792662855,-0.18550311113440499,0.7705500946477827,0.056921835217394856,0.23993301780916126,0.4762238262426934,-0.25045377370407257,0.43631683980579766,1.0543903092661777,-0.4824771414404698,-0.34920879673478605,-0.8164815290789347,-0.860269285023448,-0.18551304356644008,0.8328342816630576,-1.6662198330204645,-1.3372738841787246,1.355815655590416,-0.8452445006698698,2.871789338095357,-0.8492942753065429,-0.5060412176566478,-0.33594178796687696,0.14074519489766954,1.3570019777329814,-1.2355348597490334,0.55540482874881,1.3775721661901357,7.733333333333333,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,769.0,0.7660376280605098,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1035-T1,1.7888386911864285,0.5548090163534234,1.1613892189666124,0.5762331920066555,1.3193222253397288,0.962707083638692,0.756199417955789,1.1626769270392756,2.14816773233348,1.6231079567229438,-0.0033997104609014947,-0.11429732383342138,0.5515553996537551,1.1472632029876275,1.5537484585319914,1.0637270132587275,1.5345131057333714,-0.34907791299803054,0.2407992033348141,0.3608127470848638,-1.0256390568115135,-0.9705025698504516,0.9337592400451283,0.48548737311886697,1.7599221736419441,0.6305645187632717,0.07907453814565174,1.0308017306267407,4.0169186887770785,-0.17912735286126255,1.794612919395731,1.5274784980119842,-0.13016052758367114,0.286662761201787,0.9007433183293468,-0.7172149984410735,0.9748014575381403,0.512524787292804,0.41267002661866403,-1.0266800890243684,2.2189601691883913,-1.0708700476049102,-0.03924186869477337,12.233333333333333,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,NR,74.0,0.3191075027677233,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1036-T1,0.1096687370178725,-0.5293561414069903,-0.6726592665359271,0.9251597788875721,-0.01766805702960911,0.9440929185880998,-0.012566272372931874,-1.4092394495883782,0.9132273888134094,1.2903970523901824,0.22078856181447462,0.32110373260562464,0.9676860583197842,-0.08068968675323472,0.4494691190417277,1.1945395433992918,-0.7605851807715317,1.5612221140382352,0.2898819013922547,1.1008685261419022,0.8412817866646499,1.2457759444289742,0.13607609724070982,1.6705949209830808,0.9905773465991564,0.5751560233739131,0.7879052305825505,0.8315792874346047,2.688641062830099,0.9782882970366524,0.049942119434857137,0.08202319381597682,-0.3947753859264938,0.5249556543687317,3.8174298283475063,-0.12356793214050081,1.4777821822321118,0.9597867518707012,1.2505991714014364,-1.036984467549938,1.250096693066483,-0.7774136810743452,0.6934452941886686,12.8,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.4741980574105697,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1037-T1,2.3509749136380056,1.0125580253627013,2.1113331686025445,1.5151879917354156,1.824979187793292,2.0741227044795725,0.5031074921921775,0.9545150501389866,2.3402782681028897,2.0774466235158457,1.2934147137737384,2.170935720202482,2.36239646358313,1.4538310481547643,2.52026049742807,1.1745647499281229,0.09686785273598651,0.745059224776241,0.12853086714875442,1.0792743966035843,-0.6666247382360391,-1.056621753113301,0.5647914359813209,-0.1275957409385376,0.480972383339115,0.11464507240109903,-1.6745170635103153,0.32545088599875216,1.2744661092693157,0.3471703380756291,-1.2720123659859248,0.38373755539743204,-0.27713016208998614,0.36462730386643,0.18416278745101247,0.05579709831764662,2.383993287917076,0.28216658185534954,1.587359017402318,0.8942755958537926,2.4662058433748526,0.48962689322846503,1.3498237724580404,15.933333333333334,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,257.0,0.44153414505127253,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1038-T1,0.31011792269176724,-1.0562349059016232,0.08917878606220032,0.30139620155868074,0.49915277138255854,0.5656139242896524,0.4160006361022082,-0.03729680555996572,1.0499761985153082,1.4906437012396008,0.9257635811817216,-0.06828413091803942,0.6228194304472676,-0.06965557923100228,1.4693193036076329,0.7158584081171612,-0.9596674959036701,1.2904939363290697,0.7630824261017393,1.1322307355863581,1.236099057747976,1.9256755484853192,1.1316628156718949,1.1538442880916,0.3679939463295796,-0.28128941743680574,0.3014119997983903,0.5011592315842108,3.8524774134214255,0.3541047130380498,-0.43119952843199877,1.769502365787521,-0.2820658839306132,1.071655389741708,5.183797539664952,-0.9219296604649851,0.6322375905384164,0.17231655262946383,0.4647638999535361,-2.4767093180820243,0.5745501104258262,-2.2944852411254426,-0.33151870748060813,16.433333333333334,True,SU2CLC1,PD-L1 + CTLA4,Durvalumab + Tremelimumab,LUAD,NR,,0.4780290128624608,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1041-T1,-0.48164167840707867,-1.1889614511189892,-0.4995334458839421,-0.06800548889937084,0.21518707482693628,-0.6795215081496954,-0.03359317143214075,-1.4442034811080409,0.06724423297502902,0.019567849273336508,-1.0636728136235678,-0.6079481530023049,-0.030729857314484337,-1.172541554496555,0.3840993244193026,-0.46124942058382273,-0.8706655789804031,-0.14545596361407126,-1.1153311368429515,-0.5045086173619172,1.028718796853736,0.8110912538981241,1.198052190221401,-0.8417363488966763,1.0274352590182032,-0.43436292876628796,-0.07828040261606893,-0.06573654805594706,0.9162324040795161,1.790463233304355,-0.6714658463380556,0.01401346549144482,0.5059058908353067,-0.0024492878012194936,5.370080293537313,-0.6494779760743635,0.06885436836317868,-0.327439985714385,-0.08641458410686813,-1.6204992099710542,0.3040350806154224,-1.756845584969282,0.044976831264869475,19.166666666666668,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.7364200453304988,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1043-T2,0.7949832549584729,1.3717624368334203,0.6091453797906979,0.5088121306923161,2.1817508368113656,2.0361186522360053,1.3552701535390257,0.6454477993613639,2.6797955575670995,1.9934410345214846,1.2214339890965151,2.273312912283306,3.3052654833954733,0.9626893667639952,2.230215807413731,1.916767420471789,1.9500356121287439,1.6175773486299758,0.7172761207471483,2.0905576974216316,0.9313087679688064,1.3524260629738583,1.4556899403016534,1.0977262924199642,1.3179162511724305,1.0033910289046106,0.3369126588460743,1.0874317477658566,1.8911163573098626,1.0480920164968843,1.4598758978349924,0.18136399177205859,0.8245386737659495,1.014782288818985,3.4612854408442195,-0.0853484383744694,1.914375965427041,0.43451251895947773,1.3424575326135024,-0.8870226739503819,1.7245723416818832,-1.2744077589301783,0.76650681949936,23.366666666666667,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.27248846356768186,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-COL-1044-T1,1.0854598767078683,1.138307758127076,0.8595878528559665,1.4717414885197644,1.563428543059942,3.076217312029213,1.097923555857713,-0.08753141307708656,2.9461242788843545,3.1417521193591513,1.940634604248241,3.139047698139283,2.949395313614317,2.8240979276723497,3.0159830830069887,1.823132893138502,0.5728311813185529,1.9816882618374294,1.8811266252958918,2.3963464780187516,0.44195293578818534,-0.5781207543923116,-0.5404699129965526,-0.23564700011713272,-0.4091605897663092,0.7690003691692782,-1.0761986193682191,0.9682330409640487,1.0365367872971123,0.09378600922386883,0.02458514203311614,-0.16143250306145135,-0.23670333440320976,-0.47146555635169335,0.23351945553703532,0.5896021949817095,3.0078578255642285,0.1783007141265909,2.3015071879183604,0.8307633499579372,1.8531314358525515,0.8874080829344513,1.4257433715679615,4.6,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.16589322900564318,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1001-T1,1.0718790695945484,-0.13434077860272362,-0.086703747489408,0.5780215391613845,0.7610188532773275,0.7994362924497832,0.593713869630582,0.18134784128156373,1.2230762374045148,1.283638017225694,1.580271724865912,-0.0023175698293633282,0.9150551388102048,0.3112357640559829,0.9490757274561415,1.2487207339873538,0.005691628423739933,2.0438341709600816,1.7228300637319918,2.0030669786530817,1.765674613098084,1.7014664529776886,0.9675802299280707,0.9566708319544818,2.128219876411054,1.4203073976490401,1.742511719473404,1.7083877966515806,3.004727143269924,0.6944465765294285,1.3271421909348948,1.6167907780650899,0.017591648869495047,2.195449070469254,4.928479757707733,-1.0426637358389803,1.0006359296530645,1.1521504162152318,1.8854778565433872,-1.663101587582248,1.7810665987433156,-1.9470302477218702,0.7935571292614113,7.866666666666666,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.4739138545690412,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1002-T1,-0.7709377287305957,-0.2939059952119916,-0.5993063256855541,-0.12734041119952322,-0.3584088890035683,0.30176628987262544,-0.11413962176619787,-0.7665130139504074,0.27993781395699174,0.47896297270590665,0.7886784528086153,-0.4537412465511649,0.6179828677863048,-1.2456032506880135,0.699696097570818,0.09549878787877142,-0.6229947524837756,0.8084965362140053,0.5502457513428682,0.21729487985166462,-0.7285412355915604,-0.17862514304718005,0.3069215284863464,0.24217280541416494,0.5997913408430701,0.10769788669273989,1.9833383849200608,0.06216392706095095,3.5941530296253585,0.8385146486360333,0.24149335217314463,1.9793426112976047,0.19113517482169692,1.5384059600143443,6.380352815214212,-1.2734829345059375,0.30428797538396357,0.5578616701218319,0.16619229361597773,-0.8328153315046333,0.5883055192974086,-0.9040319170787864,0.49056641445650556,36.93333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,76.0,0.7026887569192246,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1004-T1,-0.2714426158723478,-0.18944868093393824,-0.3187277895158779,-0.29333613616904597,0.0883201426815178,0.686385850682885,0.06770133290495589,-0.5784631919009542,0.5136872828973992,1.0679882309774051,0.30664943960166463,-0.12773465662844716,0.6417093909501032,0.10466115722491444,0.8365681232314044,0.45250888265302586,0.11275218656075278,1.6212347621987917,1.3426693846545337,1.307475309266999,0.9383668830860175,1.2445309161706817,0.7700935561563569,-0.8283140478841802,0.856439493353068,0.39368381383829604,0.6879033222349585,0.5723622026610937,2.3601357431892946,0.605592506430599,0.9499321449880858,1.1682306476339208,-0.206068785123968,0.5276188696048616,4.944688307048737,-0.7438544855796365,0.6955166772487874,0.6388181213698567,0.7552257845841206,0.10111096669810102,1.3972480901222135,-0.2764122600704057,1.3946105438631793,12.1,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,155.0,0.36674242453354694,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1007-T1,-0.8247241805798047,-1.4820809835879258,-0.7575043328341725,-0.2156473023608076,-1.041166801473943,-0.2783372080219177,-1.1903514020111732,-2.0349961522033695,-0.4669641435501191,-0.4092254771803593,-0.357112304498641,-0.7027810825168204,-0.3927157255031874,-0.9419509332548283,-0.5042668700286937,0.43688275177366354,-0.4734331921374033,1.4060337710653714,0.22701946369618287,0.9017448381089141,0.06509031351919221,-0.25112724960783267,0.3278057057198631,0.945412618189263,1.519977594377633,1.5593587611920123,1.7127255152881105,1.7002817947096573,2.96186314258278,0.6927789592312619,0.9469002468924536,1.6410781557267713,0.026190986019028504,1.1732027081734804,3.1003225601537263,-1.291701861245007,0.03249992871016169,1.3101011663114133,0.6613181950927746,0.3346389575272329,-0.046994217768299255,0.47048259819099686,1.1903745606938472,0.4,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,104.0,0.7906094866658135,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1013-T1,-1.1499325760272838,-1.2081788809701166,-0.7639635128925427,-0.29156038913666477,-0.6187807381561736,0.027087034080059795,-0.6607826880831253,-0.7482839343626059,-0.22526572621986768,0.3300376400625837,1.193156856371276,-0.31800375269350717,0.38104567646250553,-0.7336659379608985,0.5665088723628751,0.4042561837055395,0.042197841966106785,-0.369420842157426,2.188485464239777,0.38374364855001686,0.6335360036909797,1.2790554735385395,0.5738649632223918,3.608434487412903,-0.7987154335763779,-0.5646069077964979,-2.263061039271109,-0.3278757091749396,-0.25183052407548245,1.1730756842548837,-1.349110226682353,-1.5284981502347685,0.4533897806282182,1.5703914081300365,-0.05684481331781538,0.19599638559358526,0.285632455094832,0.3097401888680152,1.0127067902894142,-0.9939346918463253,-0.7112849630112289,-0.6407785906226758,0.3043766786846924,1.0666666666666669,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,134.0,0.9825396261963415,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1015-T2,0.27136766624049424,-0.6067996653004675,-0.35629292324726103,0.7032197670277625,0.2723060816182031,0.6751695603118302,0.0986717053076421,-0.5472513559978056,0.9220731404530778,1.24964076806868,0.899830363804691,-0.4504173694282007,0.5816120313259322,-0.4704365740326809,0.3599652618744024,1.191653912872294,0.18359853976119195,2.25720543860125,1.2912876287835864,1.7533696379648076,1.9329973746937608,2.7544360908030328,0.6745073354515779,0.32497836656249435,0.8058085588370056,0.6780534394788035,1.881263260596006,1.1906827991927873,2.788576467535754,0.6677072191894912,1.6658951381590705,2.6989552642844137,0.005787453119844912,1.528615057649952,5.617038139695412,-0.47251390950514555,0.6668894129547417,0.831643353848818,1.1571322678629696,-2.3191102159248147,1.2857692381523302,-2.2711717428145723,0.5153682913712213,6.433333333333334,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.3584695173625113,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1017-T2,0.015075583447800554,-0.4975390744708904,-0.19354597737827275,0.6639642195756517,-0.9052553618486305,-0.29106879462761437,-1.0961498236472216,-2.4053572698569217,-0.49140242527025996,-0.2587661359834214,0.015784679781758914,0.03436009656536811,-0.4400834420193408,-0.4306039226636623,-0.6299547390767082,-0.4071322933378961,-0.25697506113819985,0.7891924880346302,0.33303283654641197,0.9011499908375656,-0.3241822735404895,-0.5710138974261152,0.452606787182141,0.16761280061585598,-2.241521552420733,-1.3865145479449459,-2.03340761360042,-1.2513868338833918,-0.7448497021846149,0.9659557585228286,-0.1350754373941646,-1.813479117338487,1.2078310539618577,1.1232371702677801,-0.1697352674303569,-0.35352152119069435,0.21823501216778535,-0.25774229481657396,0.1896982927062033,1.2590266534738908,-0.2680507415503196,1.4556370291105836,1.3519440511733973,24.7,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.7184398737234726,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1018-T1,-0.9164426933184346,-1.5330575440977676,-0.8315716539721685,-0.22029587384073748,-1.2838987589473803,-1.0780977113563721,-1.8151478266585939,-1.6399628105411932,-0.8860255606243796,-0.970987099674135,-0.3336783787155952,-0.6129327140455935,-0.4064390088137766,-1.283539207494053,-0.4712430971778158,-1.3134784669184212,0.6507987477711173,0.48258397061452807,-0.1502922579221694,0.3847573692471747,-0.5781831215259225,-1.1162665837163346,1.2674816644247235,1.1478653277143478,-1.075992207107107,0.8033828386714695,-0.7323109062173697,1.0249924753670479,0.7255206948229537,0.9693629424180392,-0.7711097620099885,0.6772683055156085,-0.38824991251352653,1.806736300853379,4.941568615793007,-1.2591783055904282,-0.9547488574604864,0.9893663166989811,-0.1593749626932119,0.19972638018887376,-1.3469486096629202,0.0684773940476562,0.8310786403239716,3.2,True,SU2CLC1,PD1 + KIR,Nivolumab + Lirilumab,LUAD,NR,126.0,0.9783708768363626,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1019-T1,-0.48406605419195414,-0.2831765238030402,-0.18476075786167234,-0.270789231659686,0.30883108704271345,0.30750432475570383,0.15337638771620637,-0.6715010375019074,0.7230745111877294,1.2183768658733245,0.6704898777607953,-0.43178347171554704,0.4698279824944527,-0.810160633135532,0.9345763511213975,0.7344037812863649,0.18016071909375939,1.1989590670942074,1.120199358755986,1.1319842842951746,1.362651161414437,2.095006623709148,0.6618651854245045,0.28703618107087975,1.4121862378499976,0.031872786419932915,0.7254200443226223,0.196320803440229,2.713466719933547,0.3024956040030258,0.30084169683041145,1.9125601228533307,-0.03127479883847449,1.08322919575738,5.853561195741911,-0.9289044879608276,0.5299107426745918,0.2617876157296123,0.626070914437777,-2.657084784722462,0.5594276952820675,-2.3107014638603847,-0.11428224980389398,9.933333333333334,True,SU2CLC1,PD1 + KIR,Nivolumab + Lirilumab,LUAD,NR,,0.5564456191158429,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1020-T1,1.020625007358906,1.1865918947894387,0.08076785295852446,1.8057678659844856,0.4439152646596013,1.5964127095795366,-0.012649077103878548,-0.5113291812129783,1.570802797313875,1.6322989260204375,1.6665100029199118,1.5781651240111372,1.4398618507454337,0.8313365255774348,0.9319390761840264,1.3275336012121421,0.8545574060262804,1.9398096351686926,1.3043489123934144,1.306676175273882,1.0076907866454603,0.5122278674173276,0.8976330780960315,0.4559237866158533,-1.4753021518914733,0.5490464683976489,1.5008144052917582,1.6461564554928396,2.182932676614273,0.5893730806892926,-0.15189936806024676,1.1475204934222898,-0.6602314176960167,1.5259667869223614,5.657162989383161,0.3912458746710878,1.4979460916252487,0.7062445406032445,1.1505272283644106,-1.0400312758564378,0.8526655306395727,0.030396652432248396,0.08125798753634289,38.73333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,R,120.0,0.3532649008743892,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1534-T1,-0.8989465379831421,-0.5773184949135871,0.1060646360776928,-0.16959692907020663,-0.7444109243380049,0.5463705124401653,-1.154764395848769,-2.114896491738552,0.16448792636046022,0.4477433688728976,0.7394551139981663,0.21229714298514535,0.07110472173367521,0.12274614441936553,-0.15875924238376146,0.20932624152728707,0.4116066063658178,1.5602768206876818,0.31517051454144157,1.9839619214112985,0.7515144193522157,-0.6481129229005064,0.3924521582957253,2.5534670987187247,2.125901280376466,1.7247656938944593,2.443360342760841,1.7497179107430985,3.8865332488632154,-0.603551426441028,1.6774389441584672,1.3714054824071453,0.4251517984428092,0.37192941755282993,-0.20288544933448863,-0.23068118570917726,0.06295160547509088,1.464187257108096,-0.22800410307491667,-0.3379733292710317,-0.10173594495295309,-0.07988027109301374,0.4554249686557213,0.3333333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.7462391886198427,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1536-T1,0.5023533752163769,0.41799203316869155,-0.3390376598725468,1.1637278560977187,0.27235868516500333,0.7796171521292069,-0.09429224133836331,-0.6639577796984624,0.929736388589585,1.0995798911533852,0.7305035424978649,0.856853506101902,1.2221558108805968,0.4920403098101138,1.0816224370378436,0.24872583711292215,-0.2709549174113576,0.9601642686162244,0.9177367398104288,1.122241567626334,1.552423095985632,1.0185412651902375,0.3786365491206703,1.2694870479272138,0.09058134128124638,1.3252276979725695,0.1330410472811678,2.094614738472851,1.4336145180991582,0.6488383364833608,-1.0569397213055445,-0.9927361704211536,-0.23938701465379555,0.07853758083855807,3.0639158545265537,-0.5374215029411201,1.3615666979700587,0.7637685300880132,1.6882499445271753,-1.172983264739042,0.6472882541580355,-1.062473230766828,0.34695112538787454,13.066666666666666,True,SU2CLC1,PD1,Pembrolizumab,LUAD,R,428.0,0.49595962324352805,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1537-T1,-0.8146687471113936,-1.1711365264515976,-0.6820903140713334,-0.3883768946570496,0.3003399547554148,0.27604395436227286,0.29421557165055506,-0.35136638360164235,0.4964439078150538,0.8723945869422983,1.0028099534860282,-0.2685981765122402,0.40373904650878983,-0.3962395852075236,0.6623790822479486,0.580531896163456,-0.4502407655471243,1.4980102079818702,1.3388846593237094,1.240269887550693,1.3346764269389209,1.945853591126463,0.46718750228753075,1.4221049132584227,1.1511531940946729,0.281218163366126,2.0914379680351027,0.7033368856621035,3.84011228235279,0.3193772629536363,0.8508055894628769,2.3011885112690424,0.8282759369592009,2.5346292501555268,5.4997519056447555,-0.9054899402578904,0.3352042932531191,0.7399066226889648,0.9489402600116391,-2.8724069546458315,0.6057660068079844,-2.794753267189512,0.07798804095340912,16.1,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.5439557693202752,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1538-T1,-0.4820694998382006,-1.0094837438174566,-0.5975516663924403,0.525782030677749,-0.22704709956891578,0.4817367317992858,-0.24475713254691248,-0.9430128516039611,0.6655013546702763,1.0344824975795615,1.2895230759154552,-0.10879500664449354,0.02405865081893445,-0.5768153260322969,0.21807417303832025,0.22541681680517206,0.1430950382599549,1.94149035007825,1.756571921963711,1.622888563343693,1.4312462768093723,1.2703735045236115,0.7419245801280334,-0.10400294662858114,0.9053218657478892,1.4278626273137385,1.776217011865902,1.891707338811223,2.5077581995601297,0.451438211999616,1.5717862440584969,1.684747588765029,0.2701495003693697,2.143610470023679,5.435177848086863,-0.7477908505415868,0.39875855048570047,1.0962159189849323,1.3587551626466048,-2.3124844095970114,0.7288492499569604,-2.0624138048026013,0.2984837688457145,2.2333333333333334,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5260518023983873,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-1539-T1,-0.4877143250709266,-1.097135790217145,-0.7093502427095868,-0.4313574961314854,-2.0177070937090877,-0.413780180579289,-2.145000213395887,-0.677312560142359,-1.2161903270300176,-0.8490321285768277,-0.7074204832647989,-0.9516500090485583,-0.9354368831821115,-1.7773887377495794,-1.0309078596512284,-1.529883829567731,0.21503564259641966,-0.3534312012962751,-0.3370127085892089,-0.15097267671633718,-0.3939154755066325,-0.7439635826373343,0.2187726650497596,1.9692528268117944,0.10233612034175354,0.32138398743115554,-0.5045859417545775,-0.025417513440762297,0.5643168430925602,0.2500147606928946,-1.2365826594054454,-0.9214012723821415,-0.6271229566049066,-0.810133081396846,0.4948141934530633,-1.6241744497714796,-0.7281581650035311,-0.44336131623346686,-0.9308517778869384,2.040337811299768,-0.38833346111036554,2.181252694814416,1.3459493279203365,12.866666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,409.0,0.6360519647144223,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0033-T1,0.8862305901494387,-0.5051459583247994,-0.0496271310904224,0.9964284076309109,0.4556069747581006,0.7496277219591541,0.3779992464785416,-0.5311664330553002,1.1678530093857173,1.2669624400874926,0.9271806527048222,0.4799352423452806,0.7507796696675748,-0.40142538221289475,0.7382390916829026,0.7173374082097951,0.39717192680405633,1.6253286166862835,0.15728005696250857,1.2293669240107237,0.3392583709434434,0.5015337271825501,0.09004668314192316,-0.46822868142317753,-0.4417717375363538,0.10098695014032003,0.8902553754517519,0.41995364799550605,1.8517066573438772,1.1108705264447023,-0.4085618196227575,0.8253829524436679,-0.27240097885036463,1.252364515908426,5.303558169109296,-0.7505374906775194,1.0835065551888128,0.5313656276108832,1.0301029496364844,-2.0601298855585277,1.2552972117370753,-1.737549288414937,0.36010600810305926,18.666666666666668,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,188.0,0.45440771320383877,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0107-T1,-0.39729286122343366,-1.2300673575997272,-0.7573381184732361,-0.6627939992832047,-1.2147571981516943,-1.038643157475473,-1.806297525157867,-2.025550283796763,-0.985607712215401,-0.6825253462768737,-0.7897944256800347,-0.8788004457892925,-0.648260117825652,-0.34538379742086356,-0.6673846169268293,-1.2160068118880045,-0.8937699047574957,-0.6288941217471407,-0.01269099840131856,-0.6151869090515012,-0.5060095128424901,-0.05867006644250682,1.14997139443021,-0.24907955651819308,0.43764619981659414,1.029994554987694,-0.732699632168371,1.357870852354979,0.7380183238662654,0.8322958458763833,0.816750203912071,-0.8090670343615002,-0.16266978554497405,-0.1574137992600018,2.628316068519606,-0.6263903471983754,-0.8600762410936683,0.9065941896732883,0.05172399894917293,-0.378562418571221,-0.36015533184721393,-0.6267184672570093,-0.36468339251703763,16.466666666666665,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.8208471219074773,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0108-T1,4.320623511978895,2.4632162204123658,4.806167825901801,2.405596180306407,2.6320772392069864,2.089102898251721,0.9099501684057582,2.590952156558589,2.3794112175570836,1.8067421964991943,1.1980271309942516,2.0608995585749055,3.870545312631316,1.4562210894146472,2.8862967736017437,3.08671462713624,3.7554067127072237,0.3608165499660042,-0.48973593919039415,0.9462703745055969,0.5629912035394176,-0.4200986638191253,1.0043173026266439,1.0169030628009577,0.3958338901583241,-0.6057812097347848,-0.5364092062391785,-0.2564452651329884,2.114825560324161,-0.5669822115948379,-1.4135572311950744,1.8762021769698174,0.6691412219611419,-1.093913315130677,3.1307037509510938,0.37468632116315037,1.535483481157474,0.08435379644970054,1.4798022514379003,-0.304419180775352,3.9394042843079857,-0.3478101458097819,0.364251043203676,36.266666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.2530885389280749,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0109-T1,-0.5477993180350237,-1.9796745926996184,-0.9121075832131396,-0.16694527793147979,-1.355548395067693,-1.1690532554753899,-2.289831635658106,-1.0501356526548329,-0.8034676069581907,-0.8962736148883971,-1.3722567678260258,-1.374341893012266,-0.6531204071808412,-1.1356056734063185,-0.8771203138880066,-1.29131399954449,0.24749331021444443,-0.38667435925968263,-0.39482193631224377,-0.8456821943506632,-0.5341360849115145,-0.28550860069001865,-0.18059999834734886,2.3373757642901025,1.2250455569370198,-0.5014633735693174,-0.054728313162701304,0.16107039420641434,0.1984165361235458,0.8734373265862648,-1.1571720813053317,-0.4187202510189408,2.13733700220687,0.09030918329164943,2.1212991965169565,-1.453650844161713,-0.9741657339251967,0.17082349944228659,-0.6605229559123756,-1.1074651528739468,-0.5492699714968051,-0.7999621969393715,1.1094374796036985,3.966666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,333.0,0.7710201594022317,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0112-T1,-0.36659558536006714,-1.666753219368211,-0.927045303401421,0.4264898934410705,-1.6590447466035336,-0.6019639073693509,-2.1871834623502036,-2.4928438501671337,-0.4787312885891947,-0.028045334194900354,0.08755747577352987,-0.8570083266124899,-0.8398697080471329,-1.19781457183898,-0.5985308815086193,-1.1595133784262288,-0.0795258568181972,-0.11251978418481651,-0.796110225530874,-1.0605464719016233,-1.0077351668241872,-0.25660544384440204,0.3271238058089651,3.0609696483758673,-1.759455273213379,0.7789780252103203,1.1143602433230193,0.8092251151589444,0.6694936095180554,0.8073870598579538,-0.9429666569479034,-0.6918336197308818,-0.4098499103016659,3.2107029331012824,1.764032745956419,-0.9940151491677858,-0.6566069520722909,0.8418168959807971,-0.5115340657929712,0.7450241888494993,-0.2780099911977452,1.2463249296791248,0.4630078908067505,20.33333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.8552527929517996,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0241-T1,2.120512419664197,0.776649650090584,1.7309225762753346,0.7471693698449685,2.9111478905307613,2.040576732863885,2.2659371943046005,3.58982682821608,2.961611316057332,2.347208712901935,1.4673526958725867,2.2474437432544545,3.8713504638548946,3.0181636573137554,2.9662912319790573,1.333906454644612,1.813737369703624,1.2196231915922184,2.5587154844861164,2.464904392808625,1.1770075733688021,-0.9282358439879043,-0.1481261821816776,-0.1252630019509459,-1.460172542638791,-3.4985502338840377,-2.8757870985254894,-3.3377183651708946,-1.8516098317726248,0.29576693610286947,-0.9151684201242979,-0.09658253653940387,0.1986957805103228,-1.3564701653767908,3.628956026876726,0.8729564504671747,1.2231509786857375,-1.603426322033752,0.7305865157048776,-0.41884762602959846,1.7964422878371487,0.12429171006785045,0.7407537577177958,31.23333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.29506497237342716,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0499-T1,-0.18211808367596893,0.4202235467410018,-0.1062200557969504,0.30387573704972076,-0.005488786280347596,1.3660874108587542,-1.5873575547288437,-1.224729781180624,0.9217619397025627,1.8149657751131174,0.761659580303302,1.7232179166243837,1.1609710460688125,0.8886811969943039,0.6350249043515177,0.9824283565901494,0.05141230765895885,0.3970026109237918,1.976686293672068,1.067402846306945,1.1980973191353792,-0.2508362913477683,0.1856228236032789,1.0868525551450998,-1.3121144537253813,-0.7232883351404994,-0.1432860328262054,-0.2745081611287294,0.8794336857259071,0.26480387550942797,-0.16398132164583318,-0.11197911104777968,3.999813399468304,-0.4798227551820074,2.0012282662863115,1.0949527176798262,1.6077970779299942,0.5442826262487384,1.1176872491849685,1.1540619581317468,0.48696387784747835,1.876143687702917,0.382932337649222,10.033333333333331,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,123.0,0.47156745000584877,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0510-T1,-0.7149389627463282,-0.7078415923851687,-0.6146106370415562,-0.05954361659277118,-0.5061608067455473,0.22738389287189137,-0.33342423314990416,-2.211524951974029,-0.6663044827651241,-0.4461825245804137,0.4153414867015542,0.2671697256981678,0.5574242492883632,-0.38536676778192447,0.42543071291501644,0.6782299735339953,1.0703343077051402,2.02648328656179,3.762196021580713,3.2905686381291357,2.4169868515759694,-0.8145778858075905,-0.45761091351250377,-0.3218698664731996,-1.2056058847587579,-2.1423661784752563,-2.4053324301310197,-2.2835157684515646,-1.9987924070714649,0.3864400164608505,1.529202783736893,-1.2214674477486196,0.713945592711576,0.06384082352784254,4.280879267578016,0.46945078297532383,-0.8864661293785061,-1.08294114859119,0.3181460938873552,-0.3844989411657706,-0.7546105326285776,-0.29689238148075,0.7804746689685828,14.966666666666669,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,150.0,0.9041231870703639,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0512-T1,0.24102248556774086,0.7509680593559481,-0.2401379762844552,0.4660569146977367,0.23599573493331974,0.6560908731464212,0.09069058527411059,-0.5337240539707304,0.9222645427484167,0.9046596268459113,1.9143767254297896,1.2662695507904407,1.6088480958825526,-0.13076667186785831,1.4771134112259188,1.3318750938810462,0.09883523785151184,2.051130089778898,2.4119753840073117,1.911241715760877,1.68068979331796,1.4753637015594312,0.9713327050961366,1.6730997653790987,0.010155485543160692,0.9333313310944835,0.34842629165547867,1.2302560444808601,1.449694087244935,0.7989974546762434,0.5140640718608246,0.7745670299148609,0.40802177735990436,1.638043601936082,5.438429482823543,-0.019033748287297363,0.762086458339181,1.185732687885262,2.2664832616018598,-0.73321776005816,1.1070402580097531,-0.6494795137429396,0.8163994860835356,15.466666666666669,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.6224304166357272,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0561-T1,-0.19869786009905507,-0.1584207017655841,0.3158313463425976,0.1511098658370646,-0.0893284716467382,0.029081637090206853,-0.7296269835840791,-1.3107776466899053,0.015010095239055594,0.8445410286737919,1.1013675667755356,-0.43945575876573356,-0.3052984784750512,1.9186810949808155,0.8320542812489488,-0.29931394278670953,0.9339258758908539,0.31112802557589486,4.525682802423894,1.8327710305040192,1.6626097554078079,-0.6707079550071824,3.488921507799421,3.9222542990964624,-2.4530199210586323,-3.3019817238620908,-1.5198446501619882,-2.3618062729911733,-2.4334152953867947,0.6715711214522493,-2.4202959257643846,-0.47067560566996075,0.4660326772590442,-0.5742246211336427,4.113287411050939,0.5079012202695596,0.06057368731271566,-1.2492575349722483,0.8002889419420884,-1.6282640561034865,-0.1902485553682175,-1.0317057122753355,-0.09392249691754988,3.4,True,SU2CLC1,PD-L1,Atezolizumab,LUAD,NR,192.0,0.8360514929881524,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0668-T1,-0.3926096718112099,-0.8991975461539773,-0.46526228330943753,-0.010101852826480675,-0.8035931494534915,0.19708585497640846,-2.1129407698758036,-0.6203908398636611,0.2549041703131323,0.8551986017944059,-1.0341601627181676,-0.7236981463872263,-0.6557533318950818,2.06326362285548,0.13187462376004516,-1.046636658552467,3.628762842502451,-1.4561106236901524,2.733311743271029,0.5779177925553926,0.6782426726997867,-1.371018086298889,4.467861918272094,5.99088279743884,-0.6668872961303105,-1.4910032256088859,-2.554930800254656,-1.0218966468117583,-1.0254299878088566,0.5674432931665241,-1.414395894323329,-1.6203660637616157,4.457414673514368,1.65081114754611,1.5812603913994128,-0.2525237244837916,-0.36274235761953727,-0.5339365827484933,-1.2409683386466615,1.5704439273309752,-0.24501156778749147,2.4311019281605337,1.295472266472218,4.133333333333334,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,2238.0,0.5924182154663126,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0790-T1,2.0984985371657627,0.9335350706767732,2.4054855305645333,0.792340460280083,1.6724108305512329,2.597287592144894,-0.045272698722762114,0.5806760466462351,2.0786742157521636,2.6464701143710325,2.7052917301809005,2.685286626910058,2.287173867105296,3.267154813849669,2.7071210163883808,2.3997040155130915,1.4574418629418164,2.110384186477895,3.9738912610762815,3.3702700330779023,2.838776139754344,1.2701897188811673,4.293690388376353,6.377084674488337,-0.7665007990415422,-1.3423194836207868,-0.7341851935779592,-1.0555063856244788,-0.18153250000407042,0.8715734647062502,-0.8174790419688022,-0.2947022789417326,1.3500512365810975,-0.7387286747673744,2.3270180590430956,1.1504216767109612,2.425519095691194,-0.44951843353908266,1.637657612856,-0.029260372833814833,1.4753390912363689,0.40712538369441376,1.115298546235222,11.033333333333331,False,SU2CLC1,PD1,Nivolumab,LUAD,R,2949.0,0.27147170979579405,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-DFC-DF0840-T1,1.209905843956375,0.6179036911499206,0.046172297502007735,1.0807886493678556,0.3833820954855863,1.383604932179651,0.07790996543515971,0.5030881196784376,1.6271659307521478,1.915830804612001,1.6464174195783055,1.3722073488176476,2.0622972594493514,0.9546700588732601,1.591403583105065,1.1595912282586622,0.7808060362088369,1.6047297320014546,0.7924938248665737,1.1998760087246685,0.5423248550501187,0.6131937406465754,0.969337687107578,0.44807627685213836,-0.29822277958302235,1.421888390732523,0.05505189422354675,1.7248762999078806,1.0747564187649679,0.8426174263975726,-0.3563012833663254,-0.4185518811265841,-0.16682853688813032,1.7140484918842636,4.98294270849353,-0.05998816117054282,1.6482487402932524,1.1982124731239885,2.5574728189254765,-0.13660073325543776,1.4399753105386095,0.13312886702342663,0.6578963889700478,9.033333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,526.0,0.4125385458960715,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MDA-1441-T1,-1.0344339348990943,-0.6573608062369857,-0.7710050931199747,-0.3784842055096207,-0.27237304347519375,0.27055926759297466,-0.8174358231098016,-0.9149708343155181,-0.14822702393567563,-0.4221350123173155,-0.03907824468863547,0.2072475198846578,0.6526970226204822,-0.9181959930773711,0.20697706215162265,0.6030225525766134,-0.4544827948848102,1.4958956716552065,0.7996467083329835,1.154686317192096,0.7414823693442406,1.0640514415422253,1.0473180704110587,-0.005378352690206666,0.6073456551484302,1.5707019952439771,0.08818093839588428,2.0456421293668727,2.0734923111160253,0.9472763347396675,0.2645854700290342,0.14840771172067332,-0.4617717928267342,-0.10706472876419587,2.3471357940671034,-1.1053382641732175,0.22251223425385439,1.4770419601803435,1.5167700018986163,-0.771115389020853,0.3662661646185826,-0.8822322056623372,0.6341108563708766,7.833333333333333,True,SU2CLC1,PD1 + CD137,Nivolumab + Urelumab,LUAD,NR,,0.6386819253465198,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MDA-1442-T1,-0.2395018723071415,-0.09175117675342385,-0.5279085734464312,-0.33135276555467863,-0.7762826725881581,-0.7068658392994502,-0.2777587374900666,-1.9285810946571273,-0.41687558755422255,-0.6471888828871114,-0.566708885173009,0.5035088143309276,0.6987492633611758,-0.3456305096739353,0.37408085295336835,-0.6000619799685438,0.19710507309648123,0.6705937004011429,0.607405992486243,0.8625898595524045,0.8553841416821687,-1.0878959231972467,-0.001702521880324898,-0.998509316134899,-0.4272172083796317,-0.8606398803771587,-0.13341014089541212,-0.41720386140862104,0.42973320853424934,0.5555880007524991,-0.35813393686641914,0.27515476336496586,-0.48838763266797514,0.44418147211474684,4.7939380701233345,-0.26216021647428217,0.2197931267592786,-0.05856230997569838,1.1397655095846606,-1.3842859045835159,-1.1410312442106139,-1.005919481094075,0.7954037231390745,16.633333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.8481701903170077,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MDA-1443-T1,0.4209197153122223,-1.020812835838158,-0.5775806173571837,0.2285345473273081,-1.196791744369195,-0.016962307292433077,-1.9828606900003662,-1.201617990905196,-0.05148381296670538,0.24960567714360044,-0.055441809319525207,-0.7923268261123184,-0.3973090466878025,0.20209536139994402,0.19979323613137695,-0.211612718016294,-0.5706179077513517,-0.1580719293057848,-0.4528447641788082,0.060911006011065354,-1.2619780649302308,-1.3500777934810833,-0.3915637713256817,1.8259366264665466,-0.7471127301079935,0.6958075701156695,0.8162235293366323,0.23602635972201705,0.08526891245341457,0.6511273568572746,-0.07057038715568953,-1.1460071795825968,0.2903298557104454,2.7582187856990994,2.3227294650916424,-1.4369939910273846,0.42529074702825415,0.3440248450759988,0.34270884289712095,1.1668177652485945,0.3970432978329843,0.768176561863473,1.077637632169985,2.2666666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.7293394028710846,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MDA-1561-T1,-0.8801385787457333,-0.9816136966978904,-0.4619721147165457,-0.14911700903601183,-0.6752386684774296,-0.20713577051958523,-0.06086504903591335,-1.7250898796415346,-0.36215232196283986,-0.3148113332886863,-0.042497764939526464,-0.06138799931790441,-0.3200727112082055,-1.0878428272685587,-0.3372491301667813,-0.38496147422707266,-0.0809076397618608,1.2441815635171574,0.3170252768577103,2.0008739189480425,0.319206158190588,0.15978030612598906,0.10036207012510984,1.0887410622053364,2.2256007339442387,1.666382023671819,1.2543636660525614,1.8015620595321957,3.851318905297179,0.1428799675541203,-0.2851441551719543,-1.054634609579051,0.29723158339630706,1.0550353396181196,4.004683336297296,-1.073725935378485,-0.3647267794891867,1.312660051048937,0.3735143685929326,-1.866425708903478,-0.7092843666664843,-1.5982579542309054,0.6470866091742008,1.7,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.8685871361575501,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MDA-1562-T1,-0.8663370975883916,-0.8622921960286831,-0.5779106440386571,-0.4942161172070377,-0.7788195580184718,-0.58176960374449,-1.0648852611690727,-1.6590447788979765,-0.2387382618388925,-0.13978078317521053,-0.6178964109575378,-0.6734194890912822,-1.018246293573455,-0.856959418985868,0.12276473148168195,0.006103723320021004,-0.09615854143758244,1.5026479060703728,-0.05784653185893172,0.4044576997888579,-0.38416350828797563,-1.0101637636863556,0.17556142454047258,0.5001045154617095,2.2947414761272396,0.13827835832487284,-2.110250341968242,0.5471684796383106,0.3439967273007623,0.8172267059191087,0.2812203539579626,-1.026571852700956,7.1240024541789335,3.4765349893446675,0.5765526200993655,-1.1744912606816842,-0.34494013691979286,0.15685829953693572,-0.15015076585965367,-1.2046260106329987,0.8661453350333681,-0.8081030075425538,0.20923573528983816,7.833333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.9999999999999998,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MDA-1631-T1,-0.35489067971182225,-1.5204627330917178,-0.5817381917275066,0.16233173272019172,-1.0459249361339853,-0.8456276967500023,-1.4790526789483016,-2.1114218581260813,-0.726295539194755,-0.4904984094805512,-0.4134039224048835,-0.9670184838670695,-0.15986508765150506,-0.9205318813457397,-0.8462665170136897,-1.5770711232131567,1.0530450450806643,-1.1049479408291438,-0.6859354131241044,-1.2852808973376102,-1.0215866936414066,-1.5189998456717813,0.3596684596055469,-0.2485515915673809,-0.832139984327971,-1.5541229075701686,-1.569156609133282,-1.262845734402115,-1.2728284095301006,0.8802167491749959,-1.8205146304197548,-1.32868706524121,0.44632568866233024,1.613507631546134,2.395098395821769,-1.4860746759523757,-0.294599976259803,-1.5301920973841898,-0.5129353246698349,1.9416074260210021,-0.8030669885363695,2.155794050354119,1.7886053874310488,19.73333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,R,755.0,0.7596857414968341,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1054-T2,-0.7944816090976858,-1.1661705096404982,-0.6927714442855989,-0.31579239707518986,-1.2499299439631888,-0.8676323665472812,-1.5369777226176573,-2.3991589855705664,-0.5181549880681524,-0.17874254786301752,-1.3236394247231462,-0.9834880200172278,-1.1970990915076773,-1.0397818529574994,-0.8359165893613366,0.051092461914738985,-0.12152273360725505,0.34659201950221064,0.17453742344484857,-0.4902841403070041,-0.9983077837090001,-1.2985647291011893,-0.47705306696257616,-0.14790586418917076,0.10249896309562205,-0.2928364915144588,-1.7179993220984435,-0.5806986071581263,-0.20600995994053475,0.7839510986057843,0.04587430745091109,-0.559564280489798,-0.23922086886822597,0.9179541693976775,0.9874732120467001,-0.8209643726622784,0.19604625133761056,-0.6142022313376074,-0.8069481910743185,0.8095284043972115,-0.49067325088849495,0.39454903312535655,0.8662200685164534,34.63333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,R,1650.0,0.8239334011169667,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1135-T2,-0.2657125244259581,-0.8493211825068858,-0.38298534322713573,0.1354418763671191,-0.2007751039641169,0.3134655442946606,-0.2641915313811464,-0.622962176937691,0.12817878193671817,0.5447048660103403,0.11793238020038069,-0.44466427103370315,-0.0243084769736651,-0.6835506142191138,-0.08112360192372992,-0.020220166197881518,-0.9668344508347876,0.6927660864646915,0.16398878975618236,0.7124313566265963,0.006604898552064807,0.18982688968924372,1.0295206964672163,3.943868400889034,1.2809919137115924,1.161617371463667,1.3010161016979918,0.9493593033858782,3.655244243031648,0.3753638321681199,-1.0563800713695135,-0.9979110951004824,-0.29675359589007,0.9368817597805125,2.7886455413273534,-0.737080551713682,0.24774259959176195,0.5981266451059308,0.743005813793665,-0.6815889069276946,-0.34785361988691466,-0.6070744521825202,1.3858785264974158,13.2,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,74.0,0.724910042822669,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1149-T1,0.6085718882533145,-0.7181865693663504,-0.10367560559918736,0.4117529826597034,0.4417481532844572,0.8145528750490072,0.0789176656777492,-0.4504531755683199,1.182696426413393,1.2893464401828254,1.596560225433937,-0.17188536168424615,0.2414861684891539,-0.16975851178260917,0.8629565220858917,0.7782695896691479,-0.19792147015358436,2.069190115794518,1.4326236444062976,1.676127269067839,1.8085625365724558,1.7927769412149306,0.15008794134232617,0.24014251824474617,1.227437089686244,1.1486696339084266,2.3096818504726935,1.5164738405708749,3.423946068547719,1.327543723930273,1.431172665710128,2.3357516405878935,0.08493578057153123,1.9426244123609782,5.370382452900042,-0.6604180498433272,0.8771595540658597,1.5221332489860795,1.2773888819038852,-1.5777781549164844,1.5414481354791063,-1.5793871326736282,0.8828956754297023,3.1666666666666665,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,342.0,0.49370768985721397,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1161-T2,1.5910523228718596,1.4512340182721202,0.5060267864856876,2.1511254116600416,1.3736712388070655,2.58064942377601,0.968396575934981,-0.09562590120763992,2.4545899758097334,2.8717422515006685,1.9151307769313155,2.07975397192751,2.1477638882375625,2.9485254153775116,2.3969428722089474,1.3031886977742442,-0.08036063184929834,1.2486721254441047,1.42546285148224,1.6366450169131666,1.4325829728441195,0.9269959647570377,0.1494929663379887,-0.46425248055792395,0.6743547559223707,1.0659051308325085,-0.46693856841069215,1.0023676722524097,1.064730945543245,0.2762867205341667,-0.6588035627390803,-0.5822284046580616,-0.3542971128144213,1.0175097333399417,1.1896732363937554,0.26638010701770903,2.5832163824313845,0.4339402576442745,2.0972468626591945,0.31736782216274595,2.1001716270157713,-0.021677775560807085,0.8150441446213094,12.033333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,191.0,0.22772107981182121,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1163-T1,-1.033086629449465,-1.2454258370660287,-0.4740983064494238,-0.3780850063553918,-0.3506045608937284,-0.06646298297458407,0.030976230169996052,-0.9336599974258966,-0.5983129278033935,-0.26320129626312494,0.28822921353675796,-0.04440244878482858,0.6916272166171934,-0.5955743818107122,-0.09705378697908808,1.1896038443575132,-0.08693372891534742,1.5825213275058283,-0.7402300284314475,1.4101267469768048,-1.3028577560830785,-0.43927270639656046,0.797597695219687,2.0709869160186765,0.8900686954154287,1.4030163256232109,0.723897522036595,1.246975545488455,2.378078102583488,0.3690554627813935,-0.5083873372717024,-1.5142591590547578,0.22872779873996676,1.0902169522706486,1.8760841467432,-0.7141795361485874,-0.5816111315713233,1.1200415490779363,0.7239495357753897,-1.1867064048250964,-0.34344463154256055,-1.0815263906320163,0.4858515614741143,31.2,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.9173723947949199,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1169-T1,-0.9692166222322794,-0.7316879438191397,-0.6136163651295427,-0.38538964330526204,-0.6369918255753426,0.5384699410671083,-1.5906388830165492,-0.9941756232078024,-0.10442921087338464,0.6321218587687777,0.6633807589849655,0.3859294875264592,-0.0410561020287222,-0.015790332827270957,-0.19871182841408683,-0.5801389927821523,0.20304142194446279,2.105965954000869,0.5741462872900925,1.9098916095570913,0.27970565810584413,-0.810070208677821,-0.2815434877389712,0.5341502884733322,0.3168718704912837,-1.0737377079185457,-0.4678098311631676,-0.28384903265280836,0.8644991625135798,0.9491653748481764,-2.064658375840558,-1.1064468238956897,-0.10587381269714327,-0.14434463192575792,1.9737798216835767,-0.8798203033957382,0.5378354201215009,0.11446779676727961,-0.21186390326786705,0.466976227584886,-0.21350855466945787,0.3729175839647837,1.3126369318244295,25.266666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,1019.0,0.6385197047895443,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1387-T1,0.0503536372641892,1.1109823593538923,0.10150060071520678,0.04777211447116895,0.04547399363050617,0.7900557914734657,-0.237278073048455,-1.3069042373532354,1.042939090668367,1.0758473956845593,1.4088805988939603,1.1994908714626706,1.3199044692314112,-0.6874709311974553,0.7516450202597619,1.0077775432279092,0.2725953277795452,1.6995951887103482,0.2787324257877446,1.331401477588578,1.2444430480557964,0.9586205664791395,1.124317370078766,0.11722098654778867,-1.1172118786753,-0.04732414767500102,0.8679668027186195,0.3999094311293241,0.6207168327802601,0.6557179534309977,0.14352950783550894,0.45753988701489967,0.33396672398152766,0.2927287565942994,5.376458644658077,0.10296079153718682,1.0485253430843555,0.21936565903391986,1.2482376233736228,0.1354389849339395,1.1014764069030993,-0.2672104687697668,1.0906881873562542,41.96666666666667,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,R,261.0,0.46582538046262245,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1411-T1,-0.8884895573930904,0.15898745652855237,-0.5798258596120495,-0.33455547576987094,-0.4747107861428196,0.30170187948755073,-0.48956817701870614,-0.9863075905420922,0.5015476093740637,0.5476660655683517,1.0715268395700195,-0.21331775721877652,0.020533675022751607,-0.06168594591120346,0.3677101399852168,-0.10156484304266976,-0.25236970326975944,1.125674698229599,1.8588236925433475,1.1580117919419637,0.8212388052474181,0.11045559293546804,0.2537068963144242,-0.007127020872632775,1.544136182851057,1.656539693248805,-0.5761561150384632,2.316797796573647,0.03285924008193576,0.2870837092958317,0.9193554840782168,-0.39118072024268563,-0.4288856060560448,0.8655423915481917,-0.13036502600704508,-0.518797003332073,0.4855991537769687,1.356218044066126,1.9698547836379552,0.25438361689518835,-0.14468433102969672,-0.042435720701980366,1.011554125759604,35.1,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.9104567556305418,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1412-T1,0.46343785588514447,1.5593829745208974,-0.05990195823371007,0.5216701683425659,0.9194374655380011,1.8954213991744735,0.022451854170365673,-0.03307364259782891,2.2303500911644916,2.0780504038360106,1.3123821174837111,1.4637193184548687,2.1583420007695335,0.493998137356541,1.7037482417941325,1.3062252691678602,-0.44646238941852456,2.059470431649513,0.7492325381753429,1.720203808619417,1.178974148925319,-0.07343031623352267,0.15996751847946689,0.9699763054775267,0.44421152390901286,0.45835195907977705,-1.5978780839295612,0.5692683771159155,-0.16838845710721664,0.45968876307331175,-0.7332499960816525,-0.7277108179893047,-0.35790535060594836,-0.7799390940771568,1.2211579977683382,0.5683058575415326,2.184558539536947,-0.0946696539899908,1.0444287777888044,-0.5691939327215568,0.8029332772649002,-0.9309997742258312,1.1327105473987304,9.933333333333334,True,SU2CLC1,PD1,Pembrolizumab,LUAD,R,1282.0,0.5537099199717646,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1413-T1,0.2501131834644404,-1.129315821885959,-0.08963138704440883,0.1327785247289325,-0.3763363309795668,0.18875867270214966,-0.9280116034047585,-1.2230159031510301,0.37840347483969267,0.5328999996586932,0.9700022320051332,-0.33499817719175407,-0.3959907109340393,-0.26638532095378764,-0.1577153476290819,0.6940960127150341,-0.2831836626246967,1.3213958153225311,0.1350903293688375,1.062973579981256,1.620934488949382,0.9905084047260467,0.44010898427348166,2.8411459998573565,2.9735825889340886,1.5982891701909931,2.7348865152090984,1.1368748042046601,4.619198040627879,-1.2846989018634862,0.04267936141958725,1.7422071414473577,0.06144520383933447,0.788425462066196,0.32907818923229293,-0.9733105218226955,0.04786240188049935,1.0538263901405065,-0.013489453592581115,-2.0619397686905203,1.2854907015264858,-2.0576869471992567,0.3738391802379035,19.83333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.4726290731084012,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1414-T1,1.55104950325229,0.03171867919589526,0.4430735123404162,1.2544498560042459,0.4696921553564088,0.8742957716801071,0.08635090958052842,-0.037958433382462,1.2947885528557466,1.1971549134343566,1.635060111175848,0.4538179884095719,0.3179330186515993,-0.012371875684940432,0.4981645247992509,1.660745487993279,1.245758092699786,1.4829895111821647,0.027372841930453307,0.9756494351423312,1.4668129254580984,1.0614445895689426,1.2622801263809544,-0.7247337734393496,0.4190357296138513,0.6459701436603412,0.7074147792750826,1.1849294137075432,1.250237867337092,1.1587126916705228,1.1474085592559138,1.8838270865128284,0.18251795347716432,1.7868943269353568,0.23015194523290478,-0.9744106095250298,1.2070209210391782,0.7321817054770707,1.6139913083761244,-0.7910020339862268,1.6686767323672493,-1.0707240673561615,0.6041535854466317,18.4,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.37351797102958845,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1415-T1,-0.19578393843569436,1.155099122957613,0.31411342352386795,0.04443494718247782,1.9494422166516165,2.31416180792055,1.4117607450357668,0.9926086668737728,2.9489739817879297,2.58735549554877,1.6516489239699752,2.396251903241967,3.288109628014875,2.0211050791180916,2.8908113597357867,1.983221669110239,0.16232889385762966,2.4866332034141605,1.6641984890681443,2.1546651320532626,1.2746897238914154,0.0848826316714409,-0.4430844850448173,-0.568906334036369,-0.03850031544333213,0.1799160820642941,-1.2964539973067655,0.15526335290991716,-0.1292587305879793,0.3910402991953826,-0.8954378404444902,-0.7608408268682316,-0.11018395313857034,-0.225497745072928,2.2325301777814803,0.28136947715394706,2.3913543030142708,-0.08555878026789866,2.0180497315053043,1.1241435350711093,1.4362046129533066,0.6454868887309326,1.452976654599638,9.533333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,672.0,0.3976489142357351,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1416-T1,0.21986255347919284,0.6682910322861023,-0.16181119302688052,0.4648203336803357,0.38583350075489603,0.909763629307817,0.5330308146263352,-0.6721716317425843,1.0782460698350418,1.2779578653122596,1.2215081072364808,0.6367505022699137,1.0082198879900273,0.14452781108145574,1.204730036795188,1.0632956527028525,-0.15701458302874974,2.4384175866992814,1.5408220515009359,1.9637703620532403,1.6438797177950446,1.5072636974639286,0.7213043168487742,-0.44436518017657856,0.6322268337558558,0.8384250331981022,-0.09579737892263593,1.056194954240554,1.7196332129033993,0.7609874183202656,0.9091211164545248,1.4902251745365613,0.582145602528791,1.4343404384546172,6.469581810753999,-0.7360687617966387,1.192591139373538,0.4780560022159406,1.765659182474922,-0.757070144031988,1.38149087487556,-1.3052696057705395,0.9764247494294731,19.566666666666663,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,469.0,0.43126681032159825,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1417-T1,-0.05818215452183947,-1.2209632158597579,-0.7966977549351266,-0.1554340209350975,-0.30066697256655345,-0.647268833681196,-0.6182477279532622,-1.0605748398958887,-0.12112352648566369,-0.1255740133230349,0.1026037520499793,-0.938457630946073,0.2545818242645213,-1.7970827767813753,-0.2324015248976945,-0.4832021535498661,-0.6282977390680269,0.41197686238995235,-0.2925083497897252,-0.23937640023042167,-0.6081314099465067,0.10379921033938426,0.6253823453622962,0.1501273992977096,-0.36161531729172536,-0.17578061194522782,1.5185475892249336,0.18455579057896282,2.055768652325895,0.8373241702140658,-0.6440045827314648,1.3137166999796337,0.9887485156729956,1.8989316860665413,6.229673515058902,-1.5503331717329374,-0.3634157048849326,0.3750291278365583,-0.30946753104477315,-1.4992626189247455,0.5468377668857366,-1.923442353420133,0.7859006925411636,20.566666666666663,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,393.0,0.7276199034543276,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1487-T1,0.38294688303422325,1.512051782767889,-0.37622723471074393,0.47202460139094277,0.00301103957605197,1.0160392889106542,-1.939945172433825,-0.9198823781468747,0.5394500396039519,0.9780040096695585,-0.28155513834457585,0.3965783834744851,1.6946353554506384,1.197326184143098,1.008006209617415,-0.6676783610554463,1.7490933387109346,0.3237725794509601,0.11344441224127137,0.4539522612508065,-0.523879271599569,-0.9693222168380138,1.9895399042752424,3.2327930939854017,-0.0946010574133721,-1.9036218606491082,-3.0043274678022454,-1.9915440655232879,-1.0272031705302578,0.31246148554500336,-1.536613033615315,-0.04126348669157136,2.7266929276591445,-1.6650098804663458,4.232879610685361,-0.2738133230582983,1.0536474406228986,-1.3777158500082434,0.1382010374693195,0.696398135782118,0.31067435517393277,0.8298786404794778,-0.8343982161642269,32.733333333333334,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.42617411518978987,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1488-T1,-0.44332354971939264,-0.6483004154838882,-0.5946292011922335,-0.6309424846319711,0.017148813216474816,0.1383592575597445,-0.5166071847095896,-0.821882419567964,-0.0337696731374696,0.37162598502010125,0.041334220239413105,-0.1778848696744906,0.032304112152079505,0.07503676300815271,0.061665512544749584,0.28914724219320953,-0.6607260311904821,0.7580118875672903,0.591714387463178,1.3493847299347115,0.7394988043893452,0.0438346613353623,1.1201808045280093,4.498434317797084,2.0053255791994373,1.573758661078063,1.49405014848493,1.3862684956502196,2.7432391358783326,0.45259088767467776,0.20649007979491255,-0.31207338840656557,-0.09370551682727593,1.914650069901625,0.7593961306703353,-1.1736830714149808,0.3365982779847849,0.7917586176806974,0.12390305305083159,-1.132117076569943,0.5667779474207371,-1.212184383467825,0.6532407041198678,30.8,False,SU2CLC1,PD1,Nivolumab,LUAD,R,902.0,0.771165615705866,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1489-T1,-0.42951800050312355,0.08345498767605486,-0.4233073677416025,0.33685079289991277,-0.11470189229695187,-0.031234716463382113,-1.1006141058968644,-1.2277242838133413,0.09998313171807889,-0.0813941534871376,0.376644045967826,0.19618910706140333,0.5337411898651403,0.01885998801443105,0.9076470552690158,0.0008108621676569786,0.9173657990814309,0.5446657317587681,0.04647986444981824,1.1223158895230994,0.20219557279353326,-1.249168821381461,1.9820453221469077,2.0765355350353136,-0.15262365326677352,0.9005592001426939,-1.4758378223601876,1.4922785086373567,0.1385439694202238,0.42759008316375174,-0.7579923681446104,-0.030681636822152136,0.40726093657306445,1.1532684150950727,3.6996694680893585,-0.7140485700176947,0.23672118407846046,0.957621408938389,0.6232904360463509,0.12956208810585282,-0.1661517350915685,-0.020528328519835624,-0.08580081745661387,27.766666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.9342429416972388,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1490-T1,0.3696189576899768,0.17295937730162042,-0.1325446582711425,-0.08762213578101163,0.6394926597455542,1.3736628827650583,-0.21118151606364172,0.5386105707149823,1.1773938427878932,1.5604155690063322,0.2985630821315495,0.7795818624023427,0.5528388414707822,-0.29712927257965965,1.3666465319311913,1.3351541577649562,3.6418563331870244,1.2587084969313012,-0.4374476164385134,0.890380948501926,-0.30960198017599977,-0.569942441981326,0.7447722621970888,0.7907279438823557,2.095429101539329,0.06540378490141043,-1.97549584503108,0.15308172901275527,0.47015212115252225,0.9539679074936035,-1.8207779193724156,0.22308691703836225,3.624443704230759,-0.35045549762915224,4.128972018078682,-0.2568532330189128,1.690815402369678,0.3044149412236391,0.7983093642302109,0.36422602737363147,1.2933417400008145,-0.1114416000899416,1.479486537828667,9.0,True,SU2CLC1,PD1,Pembrolizumab,LUAD,R,426.0,0.37818803665901085,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1493-T1,4.237045095829642,2.4468830451036254,4.507594147691774,2.4504960143257386,2.5871241785238115,2.5694878428202297,0.8334526341334675,1.6357141269133195,2.687102805499731,2.8296742657837073,1.7175623893053191,1.6364270332471558,2.5286882946213067,2.869115638362946,3.0474468074384604,1.1209946948679574,0.9844398333089474,1.6050380561248239,2.1854536886647864,2.401769866715942,2.1465330493942014,0.4654288103019615,2.5403920262923396,5.555926871016049,-0.5626617419219453,0.010286258996408273,-2.211333672033173,-0.002676775395838964,-0.3935694764612345,0.4649415035794887,-1.4241698443601574,0.7245981586658962,0.9193693636510949,0.18581759002601492,3.326047709371542,0.5243569800031653,2.1493148424515476,-0.28403531355280914,1.8279803965100856,0.47768078858138596,2.757723829577656,0.4113958384309825,0.78360179561502,4.633333333333334,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5367400186484175,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1495-T1,2.0688717321800305,0.3771831662564845,1.1242460221760375,1.2074223159752646,0.2581160019400338,0.1496709685043142,-0.07096605009244797,0.3923833947072048,0.8243641606423721,0.5740702589884704,-0.37039186595133067,-0.7741185882816286,-0.014787973212489511,-0.8447190033418241,0.2733223161080845,0.4643977752279769,0.040296667797079265,0.03913922107632737,-0.8345342014577175,0.047612609723505075,-1.119643952083553,-0.6760022887162177,0.5522401670849786,-0.23359422149046782,1.5073711490271264,1.0649450600771844,-0.5110334935813607,1.0750810365486445,2.256372098051162,0.15802511758944734,2.1812723864971333,3.7556708189651373,0.5626657940312014,1.314073915455249,4.372295704575148,-0.8074001327538189,0.35206993934731645,0.5530304050533995,0.2993464171339941,-1.6136897970079187,1.226133257329365,-1.8189892828556375,0.4829638085671274,14.766666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.6469584436653183,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1501-T1,-0.06058160848677736,-0.5095608920447329,-0.2584273484228642,0.22830514362877408,-0.13449610649628352,0.7258737480424603,-1.184023972231201,-1.461306290043775,0.41199990245159757,0.7682219330629473,0.8432847777374185,0.9058467039976061,1.1197656208223083,0.07116989350146445,0.6644937415997205,0.2085781726989973,0.3783279074341467,0.9515617732601827,1.5743939197608507,1.0591489807577332,0.3223724351104888,0.42108355879018944,0.26591864565118145,-0.19756911496037077,-0.5418346621790773,0.5017315890027734,-0.7451008166770297,0.6456431321658656,0.4663981489343112,0.8584201308187102,-1.289713596782874,-0.8922942059075398,-0.512549699568365,1.0384632595079237,-0.899630946417689,0.09471568928710394,1.1228242114274978,0.6331437019210993,1.0397034794628828,0.9343159597377455,0.8634582723268717,0.2932577659188978,1.232614390862115,20.133333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,245.0,0.6176895065424957,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1568-T1,1.7988635193542835,0.744659895704749,1.1389037896019933,0.5487565740733927,-0.007370012356785238,0.46647324541482416,-1.3808464484805523,-0.8975956295304968,0.561924272148435,0.38846975320024696,0.1467602827498202,0.43352248929532017,1.4671976822277155,-0.005143358475884952,0.4728419798215546,0.9256474614494472,1.0505576532672505,1.0956816765121078,0.5852806018336602,1.0446062018171087,0.26504167381602933,-0.4598024206153306,0.9796027424678092,0.2897540630113285,0.1490406518596447,1.1450800797013734,-0.6444237826500875,0.6433804724047362,1.5246440752620058,0.5959092379237125,1.1033561592245893,0.9826862268966471,-0.24498063937108497,-0.4306425529868908,3.0610121652804243,-0.4747249194092053,0.5759931720525797,0.9220967800939922,1.0675010971491354,0.7486661092367911,1.175252049472736,0.7399954475407434,1.2253229107707326,6.266666666666667,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,218.0,0.5367670545058162,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1572-T1,-0.6487207280284745,-0.9502713093995234,-0.3994803685700302,-0.13614123538963735,0.020973081367415495,0.27491225869084684,-1.159484571435929,-1.1873668393729078,0.18404583095352567,0.5542763315564727,0.5038427989902784,0.28494721290209335,0.7022954394120996,-0.2048893418206812,0.07736202444829546,-0.41355820851051195,-0.31156068730448133,0.5797333853060989,-0.5478106974881228,0.8819580980581893,-0.7807435723050903,-0.9796064235997299,-0.5836663075511109,0.41648657254216365,-0.7785460192961678,1.2464436357810258,-0.7623538801420229,0.6781350385671895,0.6748714864606327,0.6865715048459152,-0.07975788569346859,-0.9484503916605537,-0.15564316371156028,1.3596223956606313,-0.46179848673952484,-0.9259919709628878,0.3453804467827086,0.672111116666165,0.14800456261937422,-0.5588264891017954,-0.050126391735264925,-0.8054952943401575,0.7972452570678049,5.333333333333333,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,NR,362.0,0.7506754693788608,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1574-T1,4.26158405565968,3.1555878338106953,4.433132852093925,2.81287067370453,2.9320270907647736,2.3013045962210055,1.014860570035272,2.6101659726235593,2.4536793572423585,2.104858776377442,1.1657973431768383,1.800478955832972,3.3056043114042066,2.265477547349263,2.7188823905739135,2.287411192917927,2.7075983673493913,0.29748853281415877,-0.9702279135001272,0.9019429355063613,-0.02415200691693584,-0.2970571299401361,-0.32551772291336434,-0.20963321248383304,0.18442242560987945,-1.9682444406493467,-1.20376595626046,-1.318579879413678,1.7092349144878203,-0.7804482208924259,-1.7021090668808656,1.0103509881496608,-0.1290401517137749,-1.8680301926609961,1.1765254108625278,0.4659558115090561,1.722379185881263,-0.8281315279390578,1.1599566774069014,0.08887638181099408,3.7919010024290283,0.14892232372847564,0.7878055265155244,20.3,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.059794351086118525,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MGH-1575-T1,-0.4455802735931475,0.6432524133767866,-0.6422335769206602,0.007699765766404138,-0.6536481913854161,0.15275651515474042,-0.06915010931185928,-1.1776503329842898,0.2155866975232074,0.2795202673628546,-0.22760645303518337,-0.19136841633831717,-0.028684015038024792,-0.100211004220142,-0.0028396044275461755,-0.2663168774845756,-0.4216234868803137,1.0813309027574314,0.6805781759828756,0.8946607926564413,0.7580718919805673,0.6931038313144958,0.5528132459024652,2.1142524906406424,0.7265931057297821,1.1359466985368234,0.3858251485088292,1.2847381488203868,2.0179916524799557,0.5768572327719697,-0.9168322674342974,-0.2993131287343481,1.6844527122091992,0.7041329720900592,-0.40151365749410767,-1.052287546133612,0.453648986733026,0.6348903068453621,1.0789833833617621,0.25628406547265553,-0.34807025289891835,-0.0538033042576135,0.9554589747936739,3.3,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,344.0,0.7425038870695259,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MSK-1364-T1,-0.16718249955779996,-2.1058314004293632,-0.3469722704978093,-0.1043926797393959,-1.2265297986940304,-0.8433791500439405,-2.4345804195151777,-1.9027755347698794,-0.7150078514722228,-0.4898058747237821,-0.6216997473576215,-0.5915329700149342,0.2687405982620233,-1.5426814111700302,-0.6533175135797372,-0.4036497196655549,0.22061735333047316,-0.373914503493753,-1.2190542836385743,-0.2045607281773833,-0.21302254143805627,-0.5413988776352102,0.9994467418824524,1.6278441181709018,-0.5365701251924643,1.1339767756844756,-0.9334867799227367,1.5123830121884008,0.6889375786159402,0.3481821823446546,0.019780934245696217,-1.5558811924474059,0.17143724000283883,0.017898591631228013,3.778994555704028,0.6406222536095195,-0.5762582072765127,0.5485405043756998,0.39604147966352227,0.22647094954251243,0.02336433410149408,0.43407214437316294,-0.12576456417116996,14.466666666666669,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,R,789.0,0.8219581134629055,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MSK-1365-T1,-0.7807331514790353,-0.8480016281110295,-0.03609264218068953,-0.11306631024114927,0.19021907616271447,-0.4533187439733025,0.262997289561261,-0.3109423113159083,-0.19241729608406796,-0.25055519625931505,-0.49727670298624566,-0.3854862615014829,0.5989285204797326,-0.14022168700248358,0.2122791304599014,1.6328762505654066,0.9315079063836251,1.4029472981016295,-0.05888912462709034,1.3835432593221408,0.5203949942174926,-0.24802342815380685,1.060327904816206,3.9103074489279726,1.5754657624265185,1.2965372174075538,0.5083567620880207,0.5582718157205239,1.8001191870771214,0.31622493573066845,0.08746379165785413,-1.349115302899275,1.5784676879293618,1.4562379417068558,3.7874928081774466,-0.5027081366430813,-0.16463011787847964,0.6940510262005627,0.3065819688413785,-0.4776877640401152,-0.596343148439185,-0.9808149094905416,-0.03797683951864511,14.533333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,67.0,0.9610239827698863,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MSK-A2013-T1,1.6830417901530432,-0.08254959801859864,-0.20739627051967677,1.6569029262117185,0.4513704310213979,0.6310879760609216,0.4220751749116746,-0.19431625242157172,1.29057521780692,1.0970825262949626,0.27359353051612323,-0.4233980107310157,0.7161703698814676,0.16377938496060096,0.8123380151438352,0.8514111785110898,-0.32905086469532113,0.856677846180886,-1.0041897853451596,0.599008276812403,1.144183812197062,1.8273558496210314,0.9673262536776579,0.2690438976207955,0.8475084774709102,1.2850018621551162,1.030506316902819,1.5406511913344751,2.411595173610378,1.1100442621170399,0.6935202358399674,0.30731691114238907,1.8254783198154148,1.4445353375904206,4.14684904482998,-0.6072298737695206,0.8960727887012444,1.191344502788929,1.1842200982952018,-1.4655265269102213,1.7292537651484712,-1.4242487498576366,1.1492881592981172,10.033333333333331,True,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,153.0,0.36296714066477503,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MSK-A2014-T1,0.27855839474609423,-0.8937483634657868,-0.09212156169974081,0.30094527270791166,-0.03547695312178875,0.734813030766495,-0.08641024695660302,-1.0372383798653184,0.7005629159599079,0.949683167097427,0.3845705299597152,-0.3300276762515481,0.15612418515116352,0.4800191197405289,1.1422644772276513,1.0713536660279857,0.3001435035926446,2.1962101968313883,0.48350173769465943,1.0139270601686388,0.358843305179117,0.2636589746352807,-0.4522727932953204,0.6847774366022037,-0.10717905731475676,-0.19181787789693108,0.9746239389929231,0.30394518088272626,3.0497111087976716,1.5829815624882764,0.3570201115184343,1.1148796725419206,0.8722464602660905,1.8765118445941533,5.316772825481132,-0.8474057204113463,0.8828379555679056,0.7282945776482131,1.250332410641795,-0.6590711065069166,1.4180171539627697,-0.4127708146022766,0.8513980463881636,13.0,True,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,71.0,0.48234097075539406,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MSK-A2060-T1,1.2769517073657999,1.3170145730298812,0.8859913724060902,0.7737693862263222,1.514893650562026,2.7209409145246273,1.3507513723230373,-0.08897966810683973,2.718993389003137,2.7278322380833586,2.008619806877179,2.5387754077146423,2.085768542381589,2.18062812169369,2.4982609980399295,2.063905388167076,0.6110347410114678,2.4661110814955665,2.176525538557373,2.276029592915294,3.6732062651963093,2.850485405594307,1.8736502974428089,4.863750927275729,-1.1836249633227125,-0.21477989838734732,0.03547386258095525,0.3390644502937805,1.6737552982239452,0.7680002693470543,-0.629425860924909,0.6636851877512427,0.3314541886306304,0.3971374328225721,5.242101798072975,0.2899875189239213,2.681589878435179,-0.07865001304242643,2.338757584059965,-0.8401244504401576,2.4347174658819606,-0.7190888028093773,0.819947919716423,19.83333333333333,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,807.0,0.0,Low-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-MSK-A2075-T1,-0.5820574737037176,0.8850352176735119,-0.8004197407082626,0.2671862006546599,-0.6925249615705587,0.28250288348126856,-1.476348653068909,-1.477191526806831,0.1162469647869752,0.7760163466274733,0.6415375777301487,0.5693779018686563,0.24843556932674293,0.05396379681451016,0.2350177130233112,-1.0624736131152022,-0.0788646266330895,1.7378604288831458,-0.19818536477204518,0.9182656163111839,-0.09482783194717591,-0.5891925412493528,0.4619297128855281,0.7909512701070658,0.9100265472002508,-1.2096921627061654,-0.9503188533868788,-0.7361933470217773,0.4204883018170762,0.7644189420145134,-1.4668611517786723,-1.3497559521600013,1.4366882461151567,-0.24683378416440202,3.2054683025719792,-0.3385530464414079,0.6659661384270213,-0.25334669856841724,-0.08305221273710026,0.6817558201620132,-0.2667507505394479,0.38369178255423797,1.2739533143342276,31.266666666666666,False,SU2CLC1,PD1 + Other,Nivolumab + LAG-3,LUAD,R,,0.5793955172745571,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-UCD-1124-T1,0.2598682979910275,0.287524415362733,0.7124871743701618,0.4077188431653917,0.05086948938383466,0.360544829785995,-0.3589311596645651,-1.137104661109303,0.2120191060026745,0.5609346538794134,1.4032774339649468,0.4573265004893137,1.6148125500994142,-0.08288486060925865,0.279087820965297,0.6258719161696067,0.6886314550672615,1.7100978921045633,0.5744509102509454,1.0385482480378956,0.7473877545323523,0.9814805473230215,1.4435020596153822,2.0947702071506984,-0.18449101123972947,1.0498477084043452,1.0742325297956816,1.7231396560304024,1.6208420466403106,0.8244760638186217,-0.2611156962394271,0.7064055594105306,0.5772363257336042,1.329379749051438,5.169149449630405,0.23103913282432242,-0.10116421741350719,1.2249786115488368,1.7267076741805663,-1.1307653082180407,0.47039343537191985,-1.2118045798085797,-0.622553619945076,35.43333333333333,False,SU2CLC1,PD-L1,Avelumab,LUAD,R,157.0,0.8624422610325498,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-UCD-1142-T1,-0.3112937627108736,0.4208051817373955,-0.08441972166155377,0.6318838615159004,-0.039607924492441916,1.3957916228743361,-0.2797202549585024,-1.1625533742634426,1.1882182426265904,1.7028118104508418,0.6858316723468095,2.027507988002343,1.0157340813588565,0.46081843580201703,0.8495376341442121,0.8060556417576065,0.6283327693435308,2.114992970632702,1.2052264842781146,1.9144683616061762,-0.324777475064348,-0.8931500238935907,0.29764851035571965,0.6498284941090208,-0.455037848345225,0.06654524716607779,-0.7071750488426047,0.390269764306445,0.7085410426930171,0.584228316848779,-0.6322369399588142,-0.6031026570685406,-0.25533109839815493,-0.21480822186214918,2.253110684223108,0.16414914351346166,1.7876469951102416,0.5210414191155884,1.8298106006748107,1.3140274905227147,0.28492245691979695,1.1732239833891067,1.5803470015779408,26.1,False,SU2CLC1,PD1,Nivolumab,LUAD,R,642.0,0.4700338794416505,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-UCD-1143-T1,-0.7576746947026922,-1.1256665466536517,-0.5588588172769818,-0.058717906061975314,0.6258003894928615,1.086023069596876,0.5526679535217052,-0.3541865247376002,1.4817970764663613,1.7898312211717562,1.6806963130007022,0.4051289328516167,0.6330553088651576,0.255544127303388,1.593656600458629,1.5057555214749743,-0.6774485692014167,2.444688107841499,2.313994344283875,1.983133478193252,1.2447899419805717,1.5756471451820968,0.13954574186954385,-0.0956729726410378,1.2952136544365964,0.3914585519814655,1.6334077754752905,0.8970238349351829,3.5041081270308685,0.6056797763393432,0.570832425364714,2.0202508654957696,0.17997103812018272,1.6368936278414252,5.473410228609098,-0.7760264856000703,1.1094681106642774,0.8935014370038542,1.996778979851168,-1.6113966610281842,0.8500495066630736,-2.0232408412514733,0.9697799374499955,21.866666666666667,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.46714620913317234,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-UCD-1557-T1,0.6072484254692025,-0.2276895740962411,0.1445190802785831,0.11753005041583309,-0.20306452830643534,-0.5286055252411788,-0.4584935452619346,-1.3441144657216806,-0.21714121091456123,-0.10094360772317705,0.5732542140131602,-0.19402021633359404,0.7472380236609653,-0.640688372969019,0.07270906944249396,0.1571241877976145,0.37810448213420594,0.9075914566759865,0.8066699909580707,0.9051106524897784,-0.7398313848176243,-0.9270751948424926,1.068028707503599,0.4132986912174518,-2.072756705517872,-1.3345313512444437,1.017648122689911,-0.5483365547753067,1.7796369978536395,0.717309598964464,-1.5049339288973438,1.7096764175213568,0.5810245063216574,0.3578900559651968,6.376107109182301,-0.7364730090332299,-0.18975756521290058,0.023830500727602857,0.05019347000528499,-2.483074826739601,0.264990765113442,-1.6964107688636572,-0.5024135631011887,27.3,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.786668404408547,High-risk,55.42664520663107
NSCLC_Ravi_SU2CLC-UCD-1560-T1,3.9839623732391463,2.53915954910675,4.2583394912315065,1.9932490271443093,3.9640659076423934,2.9380459473974225,2.774130327353197,3.6856951052026465,3.2855548366101677,3.519728676756076,1.9429167398957863,1.3613914541899703,3.9825971745379194,5.395650729537046,4.281449664521449,2.256715578010156,1.867639283530166,-0.822980760885658,-1.1533929453391318,0.2949690972074221,-1.002605970866313,-0.8458218342096563,0.139272980166148,1.8551780421101831,-2.3507737582689114,-3.311914191103843,-3.894051873238028,-2.543204791527289,-0.756661070330782,-0.3243770112675964,-1.8614099604214747,0.4069783018818765,0.0192965817658107,-1.7242257155121874,2.8492696048799333,0.9350058052738253,2.5396423863063418,-1.6639586698469158,1.4704937748224138,-1.568411579980453,3.3178284562028635,-1.1056144064153584,0.07386754566944956,3.466666666666667,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,NR,,0.06330898935160734,Low-risk,55.42664520663107
